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CH APTER I

IN TRO D U CTIO N
Statem ent o f the Problem
“Anxiety disorder is the most prevalent o f all the m ajor groups o f m ental
disorders and w ithin this group, phobias are the m ost com m on disorder” (Lindem ann,
1994, p. 161). Specific phobias involve anxiety reactions elicited by a circum scribed
stim ulus (Ost, 1989). A ccording to the D iagnostic and Statistical Manual o f M ental
D isorders 4lh Edition (D SM -IV ) (American Psychiatric A ssociation, A PA , 1994),
“T h e individual experiences a marked, persistent, and excessive or unreasonable fear
w hen in the presence of, or w hen anticipating an encounter w ith, a specific object o r
situation” (p. 405). F u rth er diagnostic criteria involve the (a) phobic stim ulus
provoking an anxiety response, (b) individual recognizing the excessiveness o f the
fear and (c) avoidance o f the phobic situation fD SM -IV . A PA , 1994).
The one-year prevalence rate for experiencing a specific phobia w ithin the
norm al population is 9% and lifetim e prevalence rates range from 10%-11.3% (D SM IV , APA, 1994). T he Epidem iologic C atchm ent A rea Study sponsored by the
N ational Institute o f M ental H ealth reports lifetim e prevalence rates from 7.8% to
23.3% (Robins, H elzer, W eissm an, Orvaschel, G ruenberg, B urke & Regier, 1984).
T he lifetime prevalence rate fo r males is 7.2% and 13.9% for females according to
B ourdon, Boyd, R ae, B um s, Thom pson, & L ocke (1988). Variations in these
prevalence rates m ay be due to difficulty jud g in g im paim ient without access to an

1
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operational

definition

for

the

distress/im pairm ent

criterion

(A ntony,

M oras,

M eadow s, Di N ardo, U tech, & Barlow , 1994), o r the difficulty detecting phobias
because sym ptom s are concealed due to avoidance o f the stim uli (R eich, 1986). The
diagnosis o f a specific phobia depends on the circum stances o f the individual's life,
and “A lthough phobias are com m on in the general population, they rarely result in
sufficient im pairm ent or distress to w arrant a diagnosis o f Specific Phobia” (D SM -IV .
A PA , 1994, p. 408). K leinknecht (1991) indicates that betw een 5 % - l 0 % o f North
A m ericans suffer from a clinically diagnosable phobia. Therefore, even though
specific phobias are prevalent and effective treatments are available (Ost, 1989) many
(i.e., insects, m ice and snakes) are unlikely to cause significant im pairm ent in
functioning and result in few individuals seeking treatm ent.
A ccording to the D SM -IV (APA, 1994), anim al fears prim arily begin in
childhood. Fears of anim als are com m on among children and usually dim inish by age
six. T herefore, the onset for anim al phobia is around age seven. O st (1987) found that
anim al phobias started earlier than all other phobias studied. M arks & G elder (1966)
stated that although no sm all anim al phobias start during adulthood, individuals only
presented for treatm ent as adults. It is estimated that as m any as 40% o f childhood
fears continue into adulthood (K leinknecht, 1991). It is not clear w hat differentiates
those that lose their anim al fears in the maturation process from those that do not,
although M cN ally & Steketee (1985) suggest that differential avoidance behavior is a
p ossible explanation. T hey indicate that phobic individuals consistently avoid the
phobic anim al and in this process lim it the possibility for naturally occurring fear
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reduction (M cNally & S teketee, 1985), whereas, non-phobic individuals do not
engage in avoidance.
Animal phobia is the m o st prevalent specific fear for w om en and the second
m ost prevalent for m en (C urtis, M agee, Eaton, W ittchen, & K essler, 1998). Reich
(1986) reports that, “ ...p h o b ia is the m ost frequent em otional d iso rd er in w om en in
all age groups and one o f the m o st com m on in men as w ell” (p. 130). In addition, he
states that, “the fem ale to m ale ratio in phobias is at least 2:1” (R eich, 1986, p. 130)
and B ourdon et al. (1988) fo u n d a ratio o f 2.7:1 for fem ales and m ales w ith sm all
anim al fears. A nim al phobias also tend to occur m ore intensely in fem ales than in
m ales (Thorpe & Salkovskis, 1997).
Fears can develop fo llo w in g a traum atic experience, after observing another
fearful individual, or through inform ation transm ission (i.e., constant w arnings)
(D S M -IV , APA, 1994). T hese situations serve as conditioning events such that the
presence of the specific co n d itio n ed stim ulus (i.e., a p articu lar anim al) elicits a
conditioned arousal response. M cN ally & Steketee (1985) fo und that 71% o f the
participants who could rem em b er the fear onset attributed the fear to conditioning
experiences involving frightening, but not painful, interactions w ith the anim al. Ost
(1985) stated that 50% o f the anim al phobics reported conditioning experiences in the
acquisition of the phobia, 22.2% attributed the acquisition to m odeling and 19.5% to
inform ation or instruction. O st & H ugdahl (1981) reported sim ilar percentages with
47.5% , 27.5% and 15% respectively for animal phobias. M uris, M erckelbach, &
C ollaris (1997) found that, “ ...h ig h fearful children reported m ore conditioning
experiences with spiders than m oderate and low fearful children” (p. 934). T he fearful
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children also reported that the conditioning experiences m ade th em m ore afraid of
spiders. N early 41% o f spider phobic children were able to report the conditioning
event that initiated the fear and their parents confirm ed m ost o f these events
(M erckelbach, Muris, & Schouten, 1996). C onditioning experiences are com m on
am ong spider phobics, and conditioning and m odeling play a m ore im portant role
than inform ational learning when it com es to the acquisition o f anim al phobias
(M erckelbach, Am tz, & de Jong, 1991).
A nother theory' about the acquisition of phobias involves the familial
transm ission

o f fears. Fyer, M annuzza,

Gallops, M artin, A aronson, G orm an,

L iebow itz, & Klien (1990) report that the rate of anim al phobias is higher am ong
relatives o f anim al phobics than relatives o f control or situational phobic participants.
Fredrikson, A nnas, & W ik (1997) found that o f the anim al phobic participants, 37%
o f the m others and 7% o f the fathers had snake or spider phobia. The familial
transm ission o f phobias m ay sim ply involve the effects o f m odeling by the phobic
parent. Fredrickson et al. (1997) indicate that, “ ...th e presence o f specific phobias in
m others m ay be a more significant risk factor for the developm ent o f phobias than the
presence o f specific phobias in fathers” (p. 27). However, given that tw ice as many
w om an are diagnosed w ith anim al phobias as men, one w ould expect to find
m odeling from the m other to be m ore significant in the developm ent o f animal
phobia.
A cquisition o f anim al fears through m odeling has also been dem onstrated in
m onkeys (M ineka, D avidson, C ook, & K eir, 1984; C ook & M ineka, 1989, 1990).
C ook & M ineka (1989, 1990) show ed that m onkeys could dem onstrate a strong and
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persistent fear o f snakes by watching videotapes o f other monkeys reacting fearfully
to the snake stim uli (either real or toy snakes). M ineka et al. (1984) show ed that
m onkeys raised by parents with a fear o f snakes did not acquire a fear o f snakes
w ithout any specific experiences with snakes (i.e., the monkey did not observe the
m o th er’s fear). M onkeys that observed their m other responding fearfully to real, toy,
and m odel snakes did develop a fear response. M ineka et al. (1984) concludes that
sim ply living w ith som eone who has a fear o f snakes is not sufficient to acquire a
strong fear w ithout som e modeling experiences. Conditioning experiences w hether
direct or indirect (i.e., modeling) play a substantial role in the acquisition o f anim al
fears.
R achm an (1968) suggests that phobic reactions can be grouped by three
com ponents: subjective, autonomic, and m otor. The subjective (cognitive) aspect
involves the feeling o f intense fear and panic, to a perceived threat, including
thoughts about w hat is happening and w hat can be done about the threat. This
com ponent involves the cognitive appraisal process and the anticipatory anxiety that
occurs

(K leinknecht,

1991). The

autonom ic

(physiological)

reaction

includes

physiological changes (i.e., rapid breathing, sw eating, trembling, etc.) that occur. The
physiological and the cognitive com ponents w ork together in a feedback system
(K leinknecht, 1991). The motor (behavior) response involves actually leaving the
situation (i.e., flight) or becoming “frozen” and unable to move (R achm an, 1968).
B ehavioral responses also involve attempts to avoid (i.e., not entering situations that
m ay contain the feared stimulus) or escape (i.e., turning away or running from the
stim ulus) the feared stim ulus (K leinknecht, 1991). U nder intense levels o f threat,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

phobic individuals are likely to experience all three com ponents. Therefore, treatm ent
should incorporate each com ponent either directly o r indirectly.
Exposure therapy has proven successful in alleviating sym ptoms o f specific
phobia (C ham bless, 1990). Two prim ary types o f exposure treatment are used w ith
fears including exposure to the actual stim ulus (in vivo) and imaginal exposure (in
vitro) to self-generated images o f the feared item . T he goal of exposure therapy
involves the conditioned stimulus eliciting a different conditioned response such that
the presence o f the anim al no longer elicits heightened arousal or anxiety. T he
individual rem ains in the feared situation (i.e., in the presence of the animal) until he
or she realizes that the feared consequences do not happen (Ost, 1997b, 1997a, 1989).
In vivo exposure is preferred to in vitro exposure. In vitro exposure only
involves "contacting" the feared stimulus im aginally, w hich allows the participant to
discontinue exposure by ignoring the stim ulus. T herefore, the therapist cannot detect
if im aginal exposure is actually occurring because he or she can not see the person's
images. Furtherm ore, the participant, not the therapist, controls the am ount and
occurrence o f exposure, whereas during in vivo exposure the visual stim ulus is m ore
difficult to ignore, allow ing the therapist to control the degree and duration o f the
exposure occurring. Through controlled and system atic exposure to the actual
stim ulus, the therapist focuses on extinguishing the arousal response in the presence
of the feared anim al. Throughout exposure treatm ent, the individual is exposed to the
feared situation until the conditioned stim ulus no longer evokes the arousal response
and anxiety is dim inished. The individual rem ains in the exposure situation until
arousal is reduced w ithout escaping the anxiety experienced as the conditioned
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response. Skinner (1953) stated that, "Avoidance responses m ay be interpreted as in
part an escape from the em otional com ponents o f anxiety” (p. 179). Once the anxiety
response is extinguished in the presence of the anim al, avoidance o f the stim uli is no
longer necessary.

R eview of R elated Literature
V ariations o f exposure treatm ent have been found to reduce sym ptom s o f
anxiety disorders in general and specific phobias in particular. The first utilization o f
a single session treatm ent for animal phobias (i.e., rat/m ouse phobia) involved a
single session desensitization procedure conducted by D aniels (1974). This procedure
involved a tw o-hour desensitization session for a 15-step hierarchy. Treatm ent took
40 minutes to advance through the entire hierarchy. T he treatm ent utilized a light
hypnotic trance instead o f relaxation training. Follow ing the treatm ent procedure, the
participant was able to contact several rats w ithout tension. A six-m onth follow -up
interview indicated that the participant did not have any difficulty touching rats.
Recent studies have show n an effective exposure treatm ent for specific
phobias that involves only one session (H ellstrbm & Ost, 1995; O st, Salkovskis, &
Hellstrom, 1991; Ost, H ellstrom , Kaver, 1992; Ost, 1989, 1987, 1985; Koch, L uterek,
& Spates, 1998). O ne-session exposure treatm ent involves a m axim um of three hours
and utilizes prolonged, in vivo exposure and participant m odeling to the feared
stimulus (Ost, 1989, 1987). The participant agrees to rem ain in the exposure situation
until anxiety dim inishes. This involves approaching the feared stim ulus, allow ing
anxiety to dim inish, and continuing to approach the stim ulus m ore closely (Ost,
1989). The therapist continually models how the participant should interact w ith the
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feared stimulus. The participant gradually contacts the object by initially touching the
therapist as the therapist touches the feared object and approaches full contact with
the stim ulus alone. The participant then begins to interact w ith the object more and
m ore w ith the therapist m erely present in the room (Ost, 1989).
Individuals suitable for this treatm ent include those w ith circum scribed
phobias for one specific situation or object (animal phobias are particularly
appropriate), as well as those w ith the m otivation to alleviate sym ptom s o f phobia and
w illingness to tolerate possible anxiety during the treatm ent. T h e inclusion criteria
em ployed by Ost (H ellstrom & Ost, 1995; Ost, et al., 1991; O st, 1989, 1987, 1985)
assesses secondary gain issues related to treatment. Specifically, a participant cannot
be receiving positive consequences for their phobia prio r to treatm ent and no
predictable negative consequences are envisioned if the phobia is successfully treated.
Single-session exposure treatm ent was first em ployed fo r one case o f injection
phobia that had been present for 12 years (Ost, 1985). T he session took 90 minutes to
com plete, and heart rate and subjective anxiety m easures w ere taken throughout the
session. The positive effects o f treatm ent for this individual generalized to other
injection situations and results w ere m aintained for at least four years following
treatm ent.
O st (1987) then utilized one-session exposure to treat m ultiple specific
phobias. A multiple baseline design was used with three one-session treatm ents. Little
to no generalization effects w ere seen across phobias. H ow ever, generalization to the
natural setting for treated phobias was observed. "A clinically m eaningful change
took place only when treatm en t w as directed at the phobia in q uestion, not when some
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oth er o f the phobias were treated” (O st, 1987, p. 183). These im provem ents were
m aintained at a six-month follow-up.
In another study, Ost (1989) conducted one-session exposure treatm ent,
averaging 2.1 hours, for 20 participants w ith various specific phobias (i.e., injection,
spider, rat, cat, bird, and dog). R esults indicated that 90% o f the participants show ed a
clinically significant im provem ent (m uch im proved or com pletely recovered), which
w as m aintained through follow -up (four year average), Ost, 1989.
In 1991, Ost et al. com pared therapist-directed exposure to self-exposure for
spider phobia. This study

dem onstrated

that therapist-directed

exposure

was

significantly better than self-directed exposure at post-treatm ent and one-year followup. A lso at post-treatm ent and follow -up, 71% o f the therapist-directed group,
com pared

to

im provem ents.

6%

of the

self-directed

Furthermore, 88%

group,

o f the

displayed

clinically

significant

individuals in the therapist-directed

treatm ent, com pared to 13% in the self-exposure group, were able to com plete the
entire B ehavioral Avoidance Test (B A T) at post-treatm ent and follow -up.
Therapist-directed one-session exposure treatm ent was also superior to two
form s

o f m anual-directed (specific

spider and general

m anual)

self-exposure

(H ellstrom & Ost, 1995). T herapist-directed treatm ent was significantly more
effective than the m anual-based treatm ents at post-test and follow -up. O f the
individuals in the therapist-directed group, 80% showed clinically significant
im provem ents at follow-up.
It should be noted that no participant has ever been harm ed physically,
psychologically, or socially from com pleting one-session exposure treatm ent (Ost,
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1985, 1987, 1989; O s te t al., 1991; O st et al., 1992; H ellstrom & O st, 1995), and none
o f the participants treated with one-session exposure dropped out during treatm ent.
This is im pressive, given that drop out rates generally tend to be high w hen exposure
procedures are utilized. Ost postulates that it is probable that this treatm en t is
effective because catastrophic thoughts concerning the phobia are tested to the extent
that anxiety is no longer present w ithin a specific situation/setting (O st et al., 1991).
In addition, the one-session treatm ent is econom ical and not lim ited by the return o f
fears betw een sessions, which m ay occur w ith other treatm ents that involve m ore
sessions (O st et al., 1992).
O ne goal of the exposure treatm ent session involves the participant m anaging
his or her fear w ithin the natural environm ent w hen confronted w ith the phobic object
(i.e., spider phobic is able to remove a spider fro m the home), and achieving a norm al,
non-phobic relationship to the feared stim ulus. A second goal involves a large am ount
o f "overlearning", w here treatm ent goes beyond the first goal (Ost, 1989). This
requires that the participant be com fortable interacting with the feared stim ulus
beyond the am ount required to rem ove the stim ulus from the environm ent. For
exam ple, the participant allows the stim ulus to craw l on both hands. In doing so, the
participant is dem onstrating that he or she is capable of more than the m inim al
requirem ent for "norm al" functioning. A lthough the participant should be u naw are o f
the second goal, to prevent avoidance o f treatm ent related to fear o f this com ponent,
the therapist needs to continually w ork tow ard that goal (Ost, 1989).
O st's one-session exposure procedure utilizes cognitive and behavioral
interventions to facilitate change (Ost, 1997b and Ost, 1997a). A portion o f the
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treatm ent procedure involves counteracting the catastrophic beliefs elicited by contact
w ith the feared stim ulus (O st, 1997b). O st (1991) indicates that, "...th e m ost
im portant factor in one-session treatm ent is m aking e x p licit the patient's catastrophic
thoughts concerning the phobic situation and devising the exposure situation in such a
w ay that these can be tested out” (p. 421). H ow ever, the influence and necessity o f the
cognitive interventions w ithin

one-session exposure

has not been em pirically

dem onstrated w ithin O st's line o f research.
A behavioral one-session exposure procedure w as utilized in Koch, Luterek,
& Spates (1998) for the treatm ent o f small anim al phobias (i.e., snakes, spiders, rats,
m ice, and craw ling insects). This procedure was strictly behavioral w ithout any direct
cognitive intervention and show ed sim ilar results to O st’s w ork. T he average duration
o f treatm ent was 86.8 m inutes com pared to the 2.1 hours required for O st’s treatm ent
procedure. The treatm ent produced significant change in the behavioral, self-report,
and subjectively rated dependent measures from pretest to posttest particularly in
relation to the B ehavioral A voidance Test (BAT). C lin ically significant im provem ents
w ere produced for the treatm ent participants at posttest an d follow -up.
This behavioral one-session exposure treatm ent did not utilize cognitive
interventions and the question rem ains if a cognitive co m ponent would produce
additional benefits to this already effective treatm ent. A study conducted by O dom ,
N elson, & W ein (1978) found that guided p articipation was the most effective
treatm ent as indicated on m easures o f BAT and participant rating o f fear. H ow ever, a
cognitive restructuring treatm en t produced more change fo r heart rate than the guided
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participation and generally produced lower anxiety on all m easures. Therefore, Odom
et al. (1978) suggested that cognitive restructuring was the treatm ent o f choice for
som atic anxiety. Em m elkam p and Felten (1985) assessed cognitive processes by
having som e participants engage in adaptive thinking during an in vivo exposure
treatm ent procedure. They found that both conditions produced significant changes in
heart rate and behavioral avoidance. Significant differences betw een the two groups
w ere only seen on the cognitive m easures (Em m elkam p & Felten, 1985). Ost (1992)
conducted a case study o f a w om an with choking phobia for liquids. Exposure in vivo
was utilized initially follow ed by cognitive therapy. The exposure treatm ent alone
produced m inim al changes on w ater intake and belief ratings; w hereas, dramatic
changes resulted after the cognitive therapy began.
M attick & Peters (1988) conducted another study assessing the effectiveness
o f exposure with and w ithout cognitive restructuring for individuals diagnosed with
social phobia. The exposure and cognitive restructuring group show ed a significantly
greater increase in the percentage o f the BAT com pleted at posttest and follow-up
over the exposure only group. Both groups im proved on self-rated avoidance at
posttest; however, only the com bination group continued to im prove at follow-up
(M attick & Peters, 1988). N ew m an, H ofm ann, Trabert, R oth, & T aylor (1994)
conducted a final study assessing the treatm ent effectiveness o f a cognitive
com ponent. This study assessed cognitive change that occurred follow ing a purely
behavioral treatm ent procedure for social phobia. They found that the treatment
procedure led to changes on the behavioral, cognitive, and subjective measures
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indicating

that

cognitive

restructuring

occurs

w ithout

a

specific

cognitive

intervention.

Purpose o f the Present Study
The present study evaluated behavioral and cognitive-behavioral one-session
exposure treatm ent procedures for sm all anim al phobias across three anxiety
com ponents (cognitive, som atic, and behavioral). This evaluation o f the interventions
assessed if utilizing a cognitive intervention produced additional benefits

for

treatm ent outcom e over those produced by the behavioral one-session exposure
procedure. This study also assessed the effectiveness of program m ed generalization
when

utilized

w ith

each

treatm ent. The

effectiveness

o f the

treatm ent

and

generalization procedures w ere assessed for short-term and long-term (up to three
m onths) effects.
The present study tested the hypothesis that the behavioral one-session
exposure treatm ent procedure w ould alleviate the sym ptoms o f specific phobia as
effectively as a com parable treatm ent utilizing an additional cognitive com ponent.
This study also tested the hypothesis that the program m ed generalization procedure
w ould produce greater im provem ent in long-term outcom e than the non-program m ed
generalization procedure. T he effectiveness o f the treatment and generalization
conditions was assessed based on behavioral, subjective rating, diagnostic interview ,
and self-report m easures o f anxiety.
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C H A PTER II
M ETHODS

Participants
Forty-six participants volunteered to participate in this study (see A ppendix A
for Human Subject Institutional Review Board and Institutional A nim al C are and Use
C om m ittee approval letters). Participants were recruited from college classes,
new spaper advertisem ents, radio announcem ents, and public postings (see A ppendix
B for recruitm ent flyer and classroom solicitation script). Participants w ere selected
from a pool o f adult, m en and wom en who, according to their ow n report, w ere afraid
o f sm all anim als. T he participants indicated that they avoided contact with the
particular anim al and/or experienced extrem e distress in the presence o f the anim al.
All participants included in the study possessed phobic sym ptom s for at least
one year. T he anim al fears targeted for this study w ere snake, spider, rat, m ouse, and
craw ling insect.
Potential participants were included only if they m et diagnostic criteria for
specific phobia - sm all anim al type based on the A D IS -IV . (Brow n, Di N ardo, &
Barlow, 1994a). Participants with and w ithout a lenient E diagnostic criterion (fear
significantly interferes in the person’s life or the person has m arked distress about
having the phobia, D S M -IV , APA, 1994), were included in this study. Specifically, a
rating o f four or greater on a 0 (none) - 8 (very severe) likert scale for either
interference or distress on the A D IS-IV , (Brown, et al., 1994a) differentiated partial
14
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from full diagnostic criteria. Potential participants w ere excluded based on the
follow ing five criteria outlined by Ost: (1) phobia duration less than one year, (2) not
available throughout the follow -up period, (3) not m otivated to overcom e fear or not
prepared to tolerate a possible high degree o f anxiety during treatm ent, (4) current
positive consequences from phobia (i.e., insurance com pensation, threat o f a legal
claim , etc.), and (5) predictable negative consequences if p hobia is successfully
treated. P articipants w ere also excluded if they w ere able to engage in direct contact
w ith the feared anim al during the baseline B A T or if they h ad a history o f physical
health conditions (i.e., heart or lung disease, neurological problem s, recurring chest
pains, stroke, seizures, o r chronic headaches or ulcers w ithin the last 30 days).
Finally, participants w ere excluded if they endorsed any psychoticism item s on the
A D IS-IV (B row n et al., 1994a). Participants who reported reg u lar drug or m edication
use related to the sm all anim al phobia were also excluded if the m edication
effectively treated the phobia sym ptom s or if the participant (in consultation with the
prescribing physician) w ould not discontinue the m edication o r drug use during the
length o f the study. Sim ilarly, participants receiving effective treatm ent for their
phobia at the tim e o f the study were excluded from participating in this study.
D uring the first session, 15 participants w ere excluded from participation
based on these criteria. Seven participants were excluded based on various health
conditions such as current m igraines (three), asthm a or breathing difficulties (two),
history o f seizures (one), and chest pains or heart problem s (one). Four participants
were excluded because they did not m eet diagnostic criteria fo r specific phobia, and
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four other potential participants w ere able to handle the “feared” anim al during
baseline.
Prior to beginning the screening session, all potential participants signed an
inform ed consent (see Appendix C) that described the details and potential risks and
benefits for participating in this study. T he participants were asked to com plete seven
to ten sessions (screening/baseline, treatm ent, posttest, one, three, six, and twelve
m onth follow -ups). The total num ber o f sessions included participation through the
three-m onth follow -up. In addition, participants in the program m ed generalization
condition w ere asked to attend three treatm ent booster sessions.
T he first three sessions were conducted approxim ately one w eek apart. The
first session consisted o f the assessm ent to determ ine if the participant qualified for
the study. The second session was the treatment session, and the third session
consisted o f the posttest assessments. T h e fourth and fifth sessions were conducted at
one- and three-m onths after the treatm ent proper.
T he participants who received the program m ed generalization condition were
offered three additional generalization sessions. These sessions w ere approxim ately
30 m inutes each. O ne session was betw een the posttest and one-m onth follow-up
assessm ent sessions, and the other tw o generalization sessions w ere betw een the oneand three-m onth follow -up sessions.

D esign
A three-factor, repeated-m easures design was utilized. T he first between
groups factor consisted o f the treatm ent type (i.e., cognitive-behavioral or behavioral
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one-session exposure treatm ent procedure) and the second betw een groups factor
involved

the

generalization

type

(i.e.,

program m ed

or

non-program m ed

generalization) (see Appendix D for the diagram o f the study design and the
participant flow through the study). T he third factor is the w ithin groups factor and
consists o f four assessm ent phases (pretest, posttest, one-m onth, and three-m onth
follow -up). Each cell contained ten participants for the behavioral treatm ent and nine
participants for the cognitive-behavioral treatm ent. Each participant received a onesession exposure treatm ent procedure and a generalization condition.
Procedures

Setting
A ll assessm ent and treatm ent sessions w ere conducted in therapy room s
w ithin the D epartm ent of Psychology at W estern M ichigan U niversity. T w o separate
lab settings w ere utilized for this study. A m ajority o f the sessions were co n d u cted in
the initial individual and group therapy room s. The initial individual therapy room
m easured 1.88 m x 3.93 m and the initial group therapy room m easured 3.5 m x 6.1
m. T he other individual room was 1.9 m x 2.9 m and the group room was 3.4 m x 3.2
m. A ssessm ent sessions were conducted in the individual therapy room and the group
therapy room was used for the treatm ent session and Behavioral A voidance T est
(B A T). A large ruler extending from the doorw ay to the far wall was placed on the
floo r o f the group room. For the second treatm ent location, the door w as propped
open and the large ruler extended through the individual interview room so the ruler
length w as equivalent in both treatm ent locations. A gainst the far w all, a table was
located with a clear glass cage on top, w hich contained the feared anim al. A
videocam era w as placed in the far com er near the table.
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A pparatus
D uring the BAT and treatm ent portion o f the baseline, treatm ent, posttest and
follow -up sessions, the follow ing equipm ent was utilized: a Sony videocam era,
digital stopw atch, clock, large ruler, and anim al cage. The treatm ent snake was placed
in a cage m easuring 50.8 cm x 4 7 .0 cm x 26.7 cm and all o ther treatm ent anim als
w ere placed in a cage m easuring 62.2 cm x 32.4 cm x 31.1 cm . D uring follow -up
sessions, these cages were utilized along w ith two additional cages that m easured 40.6
cm x 26.7 cm x 21.0 cm . A ll B A T and treatm ent sessions w ere videotaped. T he
stopw atch m easured the total duration o f the behavioral assessm ents and the contact
tim e w ith the anim al w hile the clo ck was used to record the total duration o f the
treatm ent. T he large ruler determ ined the distance betw een the participant and the
feared anim al.

M easures
Each participant’s level o f anxiety was m easured according to self-report,
diagnostic interview , behavioral, and subjective measures. T he diagnostic interview
A nxiety D isorders Interview S chedule for DSM -IV: A dult V ersion (A D IS-IV ,
B row n, et al., 1994a) was utilized in this study. The follow ing self-report m easures
w ere used: (a) Fear Survey Schedule (FSS, W olpe & Lang, 1969), (b) S pider Phobia
Q uestionnaire (W atts & Sharrock, 1984) o r other specific phobia questionnaires (i.e.,
snake, rat/m ouse and craw ling insect) based on the Spider Phobia Q uestionnaire, (c)
T h o u g h t C hecklist (TC derived from W ells, 1994; Glass, M erluzzi, B iever, & Larsen,
1982; K endall & Hollon, 1989; and B eck, B row n, Steer, Eidelson, & R iskind, 1987);
(d) C ognitive-Som atic A nxiety Q uestionnaire (CSAQ, Schw artz, D avidson, &
G olem an, 1978); and (e) D istress Evaluation Scale (D EV S, G. D evilly, personal
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com m unication, N ovem ber,

1998). The behavioral m easures consisted o f the

B ehavior A voidance T est duration, contact, and distance. The subjective m easures
included the (a) Subjective Units o f D istress (SUD S) and baseline SUDS level; (b)
participant and therapist ratings o f phobia severity; and (c) participant’s rating o f
expected success o f treatm ent.

A nxiety D isorders Interview Schedule for D SM -IV : A dult Version (A D IS-IV )
T he A D IS-IV (Brow n, et al., 1994a), “ is a structured interview designed to
assess for current episodes o f anxiety disorders, and to perm it differential diagnosis
am ong the anxiety disorders according to the D SM -IV criteria (APA, 1994)” (Brow n,
Di N ardo, & B arlow , 1994b, p. 1). M ood, som atoform , and substance use sections are
included due to the high com orbidity and sim ilarity o f presenting sym ptom s betw een
these disorders and the anxiety disorders (Brow n, et al, 1994b). The A D IS-IV also
involves screening questions for psychotic and conversion symptoms and includes a
m edical and fam ily psychiatric history in order for the adm inistrator to obtain a
com prehensive evaluation o f presenting anxiety com plaints as well as any other
com orbid disorders.
T he A D IS-IV was developed over a period o f years and has been updated w ith
each diagnostic system revision. T he suggested w ording o f questions appears in bold
on the interview form and is based on years o f experience interview ing and
diagnosing anxiety disorders (Brow n, et al., 1994b). Each diagnostic section begins
w ith an initial inquiry involving yes/no questions that assess key features o f the
disorder, follow ed by dim ensional ratings o f current and past episodes o f the disorder.
Form al skip-out instructions are provided for that section if the key features o f the
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disorder are not endorsed. The second section pertains to the current episode and
contains the item s necessary for diagnosis. A t the end o f the current episode section,
several questions involve determ ining the date o f onset for that disorder and if any
past episodes o f that disorder have existed (Brown, et al., 1994b). T he A D IS-IV
requires som e clinical judgm ent in assigning diagnoses and determ ining w hen further
inquiry is necessary.
Tw o independent diagnosticians conducted separate interview s u tilizing the
A D IS-R evised (A D IS-R ) and found that reliability ratings for sim ple ph o b ia as a
principle diagnosis was a k value o f 0.82, w hich represents excellent agreem ent. The
reliability o f a sim ple phobia principal o r additional diagnosis involved good
agreem ent at 0.63 (Di Nardo, M oras, B arlow , Rapee, & Brown, 1993). T he excellent
reliability for principal diagnosis is encouraging, given that two independent raters
selected the sam e principal diagnosis. Phobias that meet the criteria for a principal
diagnosis m ay be less am biguous than less severe fears. The reliability for the
principal or additional diagnosis reflects a disagreem ent w hether the fear was
sufficient enough to w arrant a clinical diagnosis (Di Nardo et al., 1993).
The reliability o f diagnostic instrum ents relies on the diagnostic system
utilized to classify disorders and the inform ation variance. The diagnostic system
continues to im prove so that clinicians can utilize inclusion and exclusion criteria to
im prove overall diagnostic agreem ent. T he structured interview form alizes the
process through w hich the presenting problem is discussed by utilizing a series o f
predeterm ined questions (Shear, Klosko, & Fyer, 1989). The structured interview s
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also assist in standardizing interview s to reduce the differences in information
presented by the participant.
Page (1991) indicates that, “ ...reliability is a prerequisite for validity” (p.
266). If different diagnoses are reached based on the same data, than at least one
diagnosis is questionable. T he validity o f the diagnosis is also related to the validity
o f the diagnostic system that is utilized and a com parison o f the stru ctu red interview
w ith a “standard.” It is u nclear w hat “standard” should be used to validate these
interview s because the traditional clinical interview has less than perfect reliability
and validity and is the reason that the structured interview s w ere developed initially
(Peters & A ndrew s, 1995). Page (1991) also states that, “a w ell-designed structured
interview w ould perform at least as well as a trained clinician in d iagnosing anxiety
disorders” (p. 266). Therefore, the A D IS-IV (Brown, et al., 1994a) is reliable for the
diagnosis o f specific phobia. H ow ever, its validity remains dependent on the validity
o f the D SM -IV . (APA, 1994).
F or this study, the A D IS-IV was used as a diagnostic screening tool during the
first session. H ow ever, the substance use, medical history, and fam ily psychiatric
history sections were excluded because they were determ ined to be m ore invasive
than necessary for this study. In addition, the specific phobia section o f the ADIS-IV
was utilized at posttest and follow -up assessm ents to determ ine if the participants
continued to m eet diagnostic criteria for specific phobia. The diagnostic status for the
treatm ent anim al and the anim al type in general (e.g., other snakes, spiders, etc.) were
assessed separately during the posttest and follow -up sessions w ith the specific
phobia section o f the A D IS-IV . This allowed for the treatm ent effects to be studied
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separately w ith the specific treatm ent anim al and the generalization effects to other
types o f the sam e anim al.

F ear Survey Schedule
T h e F ear Survey Schedule (FSS, W olpe & Lang, 1969) is a self-report
questionnaire in w hich the participant rates 108 situations that may cause fear or
unpleasant feelings on a scale from 0 (not at all) to 4 (very much). These scores are
then converted to z-scores based on m ale and fem ale norms with low er scores
indicating less fear. The FSS has been w idely used and appears to have acceptable
reliability and validity. The test-retest reliability has been found to be 0.72 (W olpe &
Lang, 1977). In another study, K lieger & Franklin (1993) reported that reliability of
the FSS ranged from 0.62 to 0.84.
In addition to determ ining the reliability o f the FSS, the concurrent validity of
the FSS has been assessed by correlating a B ehavioral A voidance Test (B A T) with
FSS scores. K lieger & Franklin (1993) classified participants as highly fearful based
on their FSS scores and attempted to correlate this score with a behavioral avoidance
task. T he researchers found that participants identified as very afraid o f snakes on the
FSS show ed relatively small am ounts o f behavioral avoidance. K lieger & M cCoy
(1994) m odified the FSS to anchor the individual items in an attem pt to im prove the
FSS criterion validity. The original FSS instructed the participant to rate each item in
term s o f the degree to which it caused fear or unpleasant feelings (W olpe & Lang,
1977). K lieger & M cCoy (1994) m odified the instructions to only include fear
responses and provided definitions o f each rating such that selecting “m uch” or “very
m uch” fear actually represented a phobic response. A significant correlation was
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found betw een self-reported fear and approach behavior fo r both fem ales and m ales (j)
< .01) (K lieger & M cC oy, 1994). Both o f these studies utilized a BA T that involved
either touching the outside o f the cage (Klieger & Franklin, 1993) or placing a hand
partially in the cage (K lieger & M cCoy, 1994) as a m axim um step.
U tilizing the FSS allows assessm ent of possible changes in the specific anim al
phobia follow ing treatm ent, as well as comparison o f results w ith previous studies. A
factor analysis o f the FSS resulted in five factors that account for 90% o f the total
variance. F actor I consists prim arily o f small animals (i.e., w orm s, mice o r rats, bats,
crawling insects, cem eteries, harm less spiders, harm less snakes, and flying insects)
and accounts for 83.67% of the total variance on the FSS. The present investigation
exam ined both the individual feared animal item and the F actor I average score across
sessions. T he FSS was adm inistered at pretest, posttest, and follow -ups to all
participants.

Specific Phobia Q uestionnaires
T he S pider Phobia Q uestionnaire (SPQ, W atts & Sharrock, 1984) contains 43
questions to w hich the participant responds with “yes” o r “no” . Five o f these items
are know ledge-based and do not contribute to the subscales, and were, therefore,
removed from the scales used in this study. A nsw ering “yes” scored one point for
most o f th e questions, except for items 2, 9, 11, 25, and 37, in w hich “no” was scored
with one point. This measure assesses dim ensions o f vigilance, preoccupation, and
coping-avoidance, and also includes cognitive-behavioral item s (W atts & Sharrock,
1984). T he three prim ary factors (vigilance, preoccupation, and coping-avoidance)
dem onstrated adequate internal reliability (correlation coefficients o f 0.77 to 0.81)
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and m oderate correlation w ith each other (correlation coefficients o f 0.27 to 0.47).
C riterion-related validity studies confirm the utility and external validity o f these
three subscales. “The three scales perform equally w ell in distinguishing individuals
w ith phobias and norm als, and in show ing im proved scores as a result o f
desensitization” (W atts & Sharrock, 1984, p. 580). Szym anski & O ’D onohue (1994)
report a test-retest correlation of 0.94 and internal consistency at 0.62 at pretreatm ent
and 0.90 at post-treatm ent. The Spider Phobia Q uestionnaire was significantly
correlated w ith the B A T (jo < .001) (Szym anski & O ’D onohue, 1994). O ther Specific
P hobia Q uestionnaires (SPQ ) (i.e., snake, rat or m ouse and craw ling insect) m odeled
questions from the Spider Phobia Q uestionnaire (W atts & Sharrock, 1984) and w ere
developed by the present researchers. Each o f these questionnaires contained 38 item s
that the participant answers with “yes” or “no” . A gain, answ ering “yes” scored one
point except for item s 2, 9, 11, 25, and 37, in w hich “n o ” was scored with one point.
T hese scales are scored such that the low er the score, the less anim al fear.
Specific fear questionnaires generally report high internal consistencies.
Fredrikson (1983) reported that individuals w ith a higher phobia score on th eir
specific phobia scale (Spider Phobia Q uestionnaire and Snake A nxiety Q uestionnaire)
did not differ from phobic controls on other scales (public speaking, m utilation, etc.).
C orrelation betw een fear ratings and questionnaire scores is significant, and utilizing
such scales to evaluate therapeutic change is encouraged (Fredrikson, 1983). T h e
specific fear m easures were adm inistered at pretest, posttest, and follow -ups for all
participants and w ere analyzed w ith the total score and four factor scores (i.e.,
vigilance, preoccupation, coping-avoidance, and cognitive-behavioral items). T h ese
scales were utilized to m easure changes related to the p articu lar anim al fear over tim e.
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T hought C hecklist
T he T hought C hecklist (TC) was derived from W ells, 1994; G lass et al., 1982;
K endall & Hollon, 1989; and B eck et al., 1987. W ells (1994) developed the A nxious
T houghts Inventory to m easure individual vulnerability to m ultiple dim ensions o f
anxious w orry. The alpha coefficients fo r the three subscales range from 0.75 to 0.84.
T he total test-retest correlation was 0.80 and significant differences were found
betw een clinical participants and “norm als” (p < .05) (W ells, 1994).
G lass et al. (1982) created a scale to assess positive and negative self
statem ents and social interactions. The split-half reliability ranged from 0.73 to 0.86
for positive

and negative

self-statem ents

respectively. This

scale allow s

for

discrim ination betw een high and low socially anxious w om en.
K endall & H ollon (1989) developed a questionnaire to identify the anxious
self-statem ents that discrim inate highly anxious individuals from those at norm al
levels o f anxiety. The highly anxious participants dem onstrated significantly higher
scores (p < .001) than the non-anxious participants. T he split-half reliability was 0.92
and the coefficient alpha w as 0.94 (p < .001).
B eck et al. (1987) created a questionnaire that utilizes cognitions related to
danger for anxiety disorders. The alpha coefficient for anxiety was 0.90 and the testretest reliability was 0.79 (p < .001). The intercorrelation o f subscales was 0.57.
In addition to portions o f the above scales, the T C contains cognitions
identified during structured interview s conducted in a previous study (Koch, Luterek,
& Spates, 1998). The T C w as used to assess the changes in cognitions that occur as a
result o f treatm ent. The T C w as divided into positive and negative thoughts classified
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by independent raters from the graduate program at W estern M ichigan U niversity.
The TC consisted o f 43 item s. T hree item s were excluded because they were rated as
both positive and negative or neutral by raters. The TC -N egative contained 36 item s
and the T C -Positive consisted o f four statem ents. Each endorsed item was scored with
one point.

C ognitive-Som atic A nxiety Q uestionnaire

T he C ognitive-Som atic A nxiety Q uestionnaire (CSAQ, Schw artz, et al., 1978)
was designed as a 14-item anxiety sym ptom checklist w ith separate cognitive and
som atic scales (seven items each). Each sym ptom is rated on a scale from 1 (not at
all) to 5 (very much so). Schw artz et al. (1978) assessed validity by correlating the
CSAQ w ith the State-Trait A nxiety Inventory (STAI). Both the cognitive and the
som atic scales were correlated w ith the STA I (p < .001). H eim berg, Gansler, &
Dodge (1987) found a significant relationship between negative and positive
thoughts, self-report questionnaires, and SU D S to the C SA Q -C ognitive. In addition,
they found that heart rate was significantly related to C SA Q -Som atic (H eim berg, et
al., 1987). D elm onte & Ryan (1983) reported internal consistency and reliability o f
0.85 for cognitive and 0.81 for som atic scales and the correlation betw een the two
scales was 0.64.
T he CSA Q was adm inistered during all assessm ent sessions and the cognitive
(i.e., C SA Q -C ognitive) and som atic (i.e., CSA Q -Som atic) subscales w ere analyzed
separately. In addition, the participants were asked to com plete the C SA Q related to
each B A T procedure (i.e., C SA Q -B A T C ognitive and Som atic). The follow -up B A T
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consisted o f the treatm ent anim al and one or two other anim als (i.e., o th er snakes,
spiders, etc.). This involved separate C SA Q scores for the treatm ent and the o th er two
anim als (i.e., CSA Q-BAT Treatm ent C ognitive and Som atic and C S A Q -B A T O ther
C ognitive and Somatic). F or all the C SA Q scales, low er scores signified less
cognitive and somatic sym ptom s.

D istress Evaluation Scale
Portions o f the D istress E valuation Scale (DEVS, G. D evilly, personal
com m unication, Novem ber 1998) w as utilized in this study. This scale contains six
likert item s. The First three item s assess distress from 1 (none at all) to 9 (very
distressed) during the baseline session, during treatment, and a few hours after
treatm ent. T he remaining items assess level o f treatm ent intrusiveness from 1 (none at
all) to 9 (very intrusive), treatm ent acceptability from 1 (not at all) to 9 (very
acceptable), and whether the participant w ould recom m end the treatm ent to others
from 1 (not at all) to 9 (yes definitely). N o reliability or validity studies have been
com pleted on this measure. The participants com pleted this m easure during the
posttest session only.
B ehavior Avoidance Test
The Behavior Avoidance T est (B A T) consisted o f the participant being given
directions to “Approach the anim al as m uch as you possibly can and pick the anim al
up gently w hen you are ready.” Participants then approached the feared anim al as
m uch as possible until their fear was intolerable. At the participant's initial stopping
point, the assistant asked, “A re you sure that is as far as you can go, to d ay ?” This
statem ent provided a challenge for the participant w ithout undue pressure to make
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sure an optim al perform ance level was reached. The assistant recorded the duration o f
the test from beginning to end, distance step com pleted (see A ppendix E for B A T
D istance Steps), actual contact tim e w ith the anim al and the participant's overt
responses (e.g., turning away, shaking, etc.) (see A ppendix F for observer d ata
collection form ). The participant and assistant then left the room and the assistant
asked, “W ould you like to try one m ore tim e to see how far you can go?”

The

procedure outlined above was repeated for a second trial based on the p articipant’s
response to this question. An increase in contact tim e and distance steps indicated less
phobic perform ance.
Subjective M easures
Each participant reported their expected success o f treatm ent on a scale from 1
(extrem ely skeptical) to 5 (extrem ely confident) and the participant and the therapist
rated the phobia severity on a scale from 1 (sym ptom free and not disabling) to 5
(extrem ely severe and disabling). The Subjective U nits o f Distress (SUD S) was rated
by the participant on a 0 (least anxious the individual has ever been in relation to this
anim al) to 100 (m ost anxious the individual has ever been with this anim al) scale.
These m easures w ere taken during each BA T to assess the participant's level o f
distress at the baseline (B aseline SU D S) and m axim um stopping points (SU D S).
A fter com pleting each B A T assessm ent, participants reentered the room at their
baseline level stopping point and provided a SUDS rating at this consistent distance
over time. In addition, SUDS ratings were utilized throughout the treatm ent
procedure. L ow er SUD S and phobia ratings and higher expected success o f treatm ent
ratings dem onstrated im provem ent.
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Sessions

Screening/B aseline
S creening. D uring the screening session each participant read and signed the
inform ed consent (see A ppendix C) and then responded to questions from the
Screening Interview (A ppendix G). The Screening Interview addresses m any o f the
exclusion criteria for this study. The research assistant then interview ed the
participant from the A nxiety Disorders Interview Schedule for D SM -IV : A dult
Version (A D IS-IV , B row n, et al., 1994a).

B aseline. If the participant qualified for the study based on the above
m easures, then the baseline session began. If a participant did not qualify, the research
assistant concluded the session and notified the participant that he or she did not m eet
the criteria for the current study. Referral inform ation was provided for excluded
participants related to possible treatm ent options. Q ualified participants com pleted the
following: Fear Survey Schedule (FSS, W olpe & Lang, 1969), Spider Phobia
Q uestionnaire

(W atts

&

Sharrock,

1984)

or

other

animal

specific

phobia

questionnaire (SPQ ), T houg h t C hecklist (TC) derived from the follow ing W ells,
1994; Glass et al., 1982; K endall & H ollon, 1989; and Beck et al., 1987, and
Cognitive-Som atic A nxiety Q uestionnaire (CSA Q : Schw artz et al., 1978).
At this point the participant began the B ehavioral A voidance T est (BA T).
Prior to entering the group room , the assistant explained to the participant that he or
she w ould enter another room that contains the feared anim al w ithin an enclosed cage.
The cage containing the anim al was placed on a table against the wall furthest from
the doorw ay. A large ruler specifying the distance betw een the participant and the
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anim al was placed on the floor. The participant approached the anim al and at the
stopping point, reported a SU D S level. Each participant was offered a second trial.
Follow ing the B A T, the participant returned to the individual therapy room
and com pleted the C SA Q (Schw artz et al., 1978) specifically for the BAT. Finally,
the participant rated his or her expected success o f treatm ent and phobia severity,
w hile the research assistant also rated the severity o f the participant’s phobia
sym ptom s. B efore leaving, the participant was asked to schedule an appointm ent for
the treatm ent session.

T reatm ent
Participants were random ly assigned to one o f tw o treatm ent procedures,
cognitive-behavioral or behavioral one-session exposure. B oth treatm ents involved
gradual exposure and m odeling. The goal o f treatm ent w as to have the participant
hold the anim al for at least one minute (not exceeding three m inutes) w hile reporting
m inim al anxiety (SUDS less than 20).
C ognitive-B ehavioral

Treatm ent.

The

cognitive-behavioral,

one-session

exposure procedure was based on the work o f Ost, L-G. (1997b, 1997a, 1989, 1987),
O st, L.-G ., Salkovskis, P. M. & Hellstrom, K. (1991) and H ellstrom , K. & Ost, L.-G.
(1995). This treatm ent involved both cognitive and behavioral interventions for small
anim al phobias. The participant was provided with a card, at the end o f the baseline
session, that contained coping self-statements. These

statem ents

pertained to

preparing to confront and confronting the anim al, coping w ith feeling overw helm ed,
and positive statem ents o f accom plishm ent. Participants w ere encouraged to read
through the card betw een the baseline and treatm ent sessions. T he therapist discussed
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the participant’s thoughts that accom panied the anxiety reaction in relation to the
p articular animal as well as the coping statem ents from th e card. T he therapist also
looked at the Thought C hecklist to becom e aw are o f w hich thoughts the participant
endorsed as occurring in the presence o f the animal. T h ro u g h o u t the treatm ent
process, the therapist challenged these specific thoughts w hile continuing the
behavioral exposure procedure. Specifically, the cognitive intervention did not
distract from the exposure treatm ent. In addition, the therapist encouraged the
participant to utilize the self-statem ents listed on the card. T hrough this process the
therapist focused on dem onstrating to the participant that the consequences he or she
fears do not actually occur. If necessary, the therapist assisted the participant with
developing coping statem ents to utilize w ithin the treatm ent session. T he treatm ent
m anual developed by O st (1997b) was follow ed with m in o r m odifications to allow
for few er significant differences betw een the tw o treatm ent procedures. In addition to
the cognitive com ponents, participants in this treatm ent group also received the
behavioral treatment.
Behavioral T reatm ent. The second treatm ent tech n iq u e involved a strictly
behavioral treatm ent procedure utilized in a previous study (K och, L uterek, & Spates,
1998). This treatm ent procedure consisted o f the therapist providing instructions for
and m odeling each treatm ent step. A t first, the participant observed the therapist
com pleting each task and then either com pleted that step along w ith the therapist or
on his or her own. Initially, participants were allow ed to touch the th erap ist’s elbow,
forearm , and then hand, follow ed by the therapist touching the p articip an t’s hand,
forearm and then elbow fo r gradual increased interaction w ith the anim al prior to the
participant com pleting the step independently. T he participant provided a SUDS level
at each treatment step/skill. T he participant was allow ed to signal for a break by
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saying “pause” instead o f m oving abruptly o r dropping the anim al. If the participant
said, “ pause” the therapist w aited fo r one m inute before resum ing treatm ent.
T he successful term ination criteria for both treatm ent procedures involved the
participant com pleting all treatm ent steps (see Appendix H for the treatm ent steps per
anim al) with little to no reported subjective anxiety (SU D S less than 20). A ll the
treatm ent steps were recycled until the SU D S ratings w ere below 20 for each step.
T he final treatm ent step involved holding the animal for at least 60 seconds. W hen the
treatm ent was com pleted, the therapist and participant exited

the room

and

im m ediately com pleted the B A T and questionnaire/ratings as described above.
T reatm ent could also be term inated if the participant experienced an extrem e
em otional reaction based on the th erap ist’s clinical judgm ent, or the participant stated
that he o r she w ould like to term inate treatm ent, or the th ree-h o u r session tim e limit
w as reached.
In order to rem ain co n sisten t w ith previous studies, the treatm ent session was
videotaped to allow the participants to w atch their video at the posttest session if
desired. This was done to let the participant see that he or she brought about the
treatm ent change and the therapist only assisted with the treatm ent. The videotapes
w ere also utilized to assess treatm ent integrity where a trained ob serv er rated the
com ponents of the treatm ent to ensure the procedures were follow ed as specified.
Im m ediately follow ing treatm ent, participants exited the room and com pleted
the B A T as outlined above including an optional second trial. A fter the B A T was
com pleted, the participants reentered the group room at their b aseline B A T distance
and provided a SUDS rating at this point. Then the participants com pleted the TC
related specifically to treatm ent and the C SA Q -B A T (Schw artz et al., 1978), fo r the
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B A T . Finally, subjective ratings were provided including therapist and participant
ratings o f phobia severity (during the B A T) and participant’s expected success of
treatm ent.

Posttest
T he posttest session was scheduled approxim ately one w eek after the
treatm ent session. During this session, participants com pleted the follow ing measures:
A D IS-IV (B row n et al., 1994a) specific phobia section, FSS (W olpe & Lang, 1969), a
specific fear m easure for the participant's phobia, TC, C SA Q (Schwartz et al., 1978),
D EV S (G. D evilly, personal com m unication, N ovem ber, 1998), BAT, C S A Q for the
B A T , and subjective ratings. Each participant was interviewed on the A D IS-IV
Specific Phobia Section in relation to the specific treatm ent animal and those type of
anim als in general (i.e., other snakes and spiders). Follow ing the BAT, the participant
w as offered the opportunity to watch his or her treatm ent videotape.
The treatm ent participants from each group were then random ly assigned to
eith er a program m ed generalization o r a non-program m ed generalization subgroup.
T he participants receiving the program m ed generalization condition w ere asked to
attend one additional session betw een posttest and one-m onth follow -up and two
additional sessions between one- and three-m onth follow-ups. These opportunities
involved approxim ately 30 m inutes o f unstructured interaction with the treatm ent
anim al and tw o additional types o f that anim al. The treatm ent animals consisted o f a
rose-hair tarantula, com snake, brow n m ouse, w hite and black rat, and M adagascar
hissing cockroach. The additional anim als fo r the generalization condition w ere house
spider, w olf spider, fox snake, garter snake, black m ouse, w hite m ouse, tw o different

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

size w hite rats, millipede and superw orm . The participants com pleted the A nim al
Interaction Form (see Appendix I) in relation to these experiences. T he non
generalization subgroup was not offered these generalization opportunities. In case
the non-generalization group m embers happened to encounter the feared anim al, both
groups w ere asked to record interactions w ith the “feared” anim al throughout the
follow -up periods (see A ppendix I fo r d ata collection form). T herefore, d ata
collection on every animal interaction outside o f the study was attem pted.

O ne- and Three-M onth Follow -ups
T he follow -up sessions occurred one- and three-months follow ing the
treatm ent session. The follow-up sessions w ere conducted exactly like the posttest
session outlined above except participants were not given the opportunity to view the
treatm ent videotape or com plete the D E V S, (G. D evilly, personal com m unication,
N ovem ber, 1998). In addition, the follow -up B A T included the treatm ent anim al and
tw o additional types of animals (e.g., w o lf and house spider, fox and g arter snake,
etc.) listed above for the generalization sessions. All participants were asked to
approach one anim al (of their choice) and then the entire BAT was repeated w ith each
additional anim al including the option for tw o B A T trials per anim al. C om pleted
A nim al Interaction data sheets (A ppendix I) w ere collected from all participants
during the follow -up sessions for any non-laboratory interactions with the feared
anim al.
A dditional R esearch Procedures
All research assistants were trained in the study procedures. Specifically,
detailed instructions were follow ed for each session including specific instructions
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that the assistant read to the participant. All therapists received the treatm ent m anual
for both treatm ent procedures. Following training in the assessm ent and treatm ent
procedures, assistants w ere supervised and observed by the investigator. All research
assistants attended regular team meetings to provide further clarification and training,
and to answ er questions throughout the course o f the study. Six research assistants
com pleted the assessm ent and treatm ent sessions. Five o f these assistants w ere
students in the doctoral program in clinical psychology at W estern M ichigan
U niversity and the other assistant was an advanced undergraduate student w ho
assisted on the previous study (Koch et a!., 1998). In addition, five undergraduate
assistants scored and recorded data, conducted reliability checks, and facilitated
program m ed generalization sessions. G raduate students, other than the investigator,
conducted a m ajority o f the screening/baseline sessions. D ifferent assistants w ere
used for the assessm ent and treatm ent sessions. In addition, assistants that conducted
program m ed generalization sessions did not com plete follow -up assessm ents for that
participant. P articipants were random ly assigned to treatm ent therapists based on
scheduling availability and treatm ent animal (i.e., one assistant did not w ork w ith
spiders and another snakes).
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CHAPTER m
RESULTS
Prelim inary A nalyses
Eight individuals w ho were selected to participate did not com plete the study
(three participants were assigned to the behavioral treatm ent and five the cognitivebehavioral treatm ent). Five o f these participants dropped out o f the study betw een the
b aseline and treatm ent sessions and the other three dropped ou t betw een the treatm ent
and posttest sessions. Five o f these participants could no t be contacted after several
attem pts, two reported that they w ere “too busy” , and one participant m issed several
scheduled appointm ents for undisclosed reasons.
Eleven participants did not com plete the one-m onth follow -up assessm ent
(eight in the behavioral treatm ent and three in the cognitive-behavioral treatm ent) and
19 individuals declined the three-m onth follow-up session (11 in the behavioral
treatm ent and eight in the cognitive-behavioral treatm ent). Figure 1 depicts the
dropout for each follow -up session by the treatm ent and generalization conditions.
T he three-m onth follow -up dropout rate includes those participants who dropped out
p rior to the one-m onth follow -up as well as prior to the three-m onth follow-up.
N on-param etric tests indicated that significant dropout occurred from posttest
to one-m onth follow -up, from one-m onth follow -up to three-m onth follow -up, and
from posttest to three-m onth follow -up (p < .01 for all three com parisons). For the
tw o treatm ent conditions, a significant difference occurred betw een posttest and one36
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m onth follow -up for the behavioral treatm ent (jo < .01), between one- and three-m onth
follow -up for the cognitive-behavioral treatm ent (£ < .05), and for both treatm ents
from posttest to three-month follow -up (£ < .01). A significant difference was found
in dropout rates from the posttest to one-m onth follow-up for the behavioral
treatm ent, programmed generalization condition only (jo < .01). N o significant
differences were found for dropout rates betw een the two follow -up sessions for any
o f the four groups; however, dropout rates betw een posttest and three-m onth follow up w ere significant for both program m ed and non-program m ed generalization for the
behavioral treatment and cognitive-behavioral treatment, program m ed generalization
groups.
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F igure 1.

Percentage of P articipant D ropout D uring Follow-up Sessions for the
four Groups.

T o assess the differences betw een com pleters, non-com pleters, and dropouts, a
O ne-W ay ANOVA with Tukey com parison was completed for all m easures. The
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participants w ho did not com plete treatm ent had significantly m ore severe baseline
scores on SPQ total, C SA Q -Som atic, and participant rating o f phobia sev erity (j) <
.05 for all three). N one o f the other m easures differed significantly betw een groups,
including diagnostic status at pretest. Participants w ho dropped out p rio r to the onem onth follow -up attained significantly low er scores on BAT D istance (2 < -05) and
reported significantly

m ore distress during the treatm ent session

(p> <

.05).

Participants who dropped out prior to the three-m onth follow-up show ed significantly
m ore distress (p < .05) during the first session com pared to participants w ho fully
com pleted all sessions.
W ithin the program m ed generalization condition, eight participants com pleted
the first generalization session only and seven individuals participated in all three
generalization sessions. O f the 19 participants in the generalization co n d itio n , four
individuals did not com plete any generalization sessions.
The participants in this study were prim arily Caucasian, single w om en w ho
w ere college students and w orked in part-tim e positions without previous treatm en t or
m edications for anxiety (see Table 1 for the dem ographic data on the subjects).
The mean age and years o f education for the behavioral participants was 24.65
and 14.5 respectively and 24.33 and 14.39 fo r the cognitive-behavioral group.
R eliability o f the B A T A ssessm ent
Interobserver agreem ent for scores on the B A T was taken during 22.5% o f the
sessions. This ranged from 18-30% across the total num ber o f sessions for all
participants. The overall interrater reliability for trial one distance was 83% , and 79%
for the second trial. The reliability o f SU D S rating was 97% for trial one and 100%
for trial two.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

39
Table 1
Frequency and Percentage of D em ographic C haracteristics Between G roups

B ehavioral
T reatm ent

C ognitive-B ehavioral
T reatm ent

Full

10(50% )

7 (38.9% )

Partial

10 (50% )

11 (61.1% )

Fem ale

13 (65% )

15 (83.3% )

7 (35% )

3 (16.7% )

C aucasian

16 (80% )

16 (88.9% )

A frican A m erican

2 ( 10%)

1 (5.6% )

H ispanic

1 (5%)

0 ( 0 %)

A sian/C hinese

1 (5% )

1 (5% )

Yes

16 (80% )

16 (88.9% )

No

4 (20%)

2 ( 11. 1%)

Single

15 (75% )

14 (77.8% )

M arried

4 (20% )

3 (16.7% )

D ivorced

0 ( 0 %)

1 (5.6% )

M issing D ata

1 (5% )

0 ( 0 %)

Part-tim e

10 (50% )

13 (72.2% )

Full-tim e

3 (15% )

1 (5.6% )

S tudent Only

6 (30% )

2 ( 11 . 1%)

M issing D ata

1 (5% )

2 ( 11. 1%)

Phobia Criteria

Sex
M ale
Race

C urrent Student

M arital Status

Em ploym ent
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Table 1-Continued

Behavioral
Treatm ent

C ognitive-B ehavioral
Treatm ent

No

16 (80%)

15 (83.3% )

Yes

3 (15%)

3 (16.7%)

M issing D ata

1 (5%)

0 (0%)

No

18 (90%)

16(88.9% )

Yes

I (5%)

2 (11.1%)

M issing D ata

1 (5%)

0 (0%)

No

18 (90%)

16(88.9% )

Yes

1 (5%)

2 (11.1%)

M issing D ata

1 (5%)

0 (0%)

Spider

11 (55%)

8 (44.4%)

Snake

5 (25%)

5 (27.8%)

C raw ling Insect

4 (20%)

0 (0%)

M ouse

0 (0%)

3 (16.7%)

Rat

0 (0%)

2 (11.1%)

Children

Past Treatm ent for A nxiety

Anxiety M edications

Animal

Treatm ent Integrity
T reatm ent integrity ratings were obtained for 24% o f the overall treatm ent
sessions including 20% o f the behavioral treatm ents and 28% o f the cognitivebehavioral treatm ent conditions. All treatment conditions w ere im plem ented properly
and none o f the participants in the behavioral condition received the cognitive
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intervention or discussed their thoughts. T he primary treatm ent com ponents were
com pleted 100% for both groups. For the cognitive-behavioral treatm ent condition
this com ponent included review ing coping statements from the card, contradicting
negative thoughts and beliefs, and not allow ing the cognitive intervention to interfere
w ith the exposure procedure. T he behavioral treatment procedure did not utilize any
o f these components.
D iagnostic Outcomes
All participants m et D SM -IV diagnosis for specific anim al phobia with the
utilization o f a lenient E criterion (i.e., the phobia does not necessarily interfere with
the person’s normal routine or the phobia does not cause extrem e distress) (APA,
1994). H alf of the participants in the behavioral treatm ent m et full diagnostic criteria
w ithout the lenient E criterion, w hile 38.9% o f the cognitive behavioral participants
m et full criteria (see Table 1) at baseline. The length o f the anim al fear for the
behavioral participants ranged from 7 to 35 years (M = 17.55) and 3 to 38 years (M =
16.39) for the cognitive-behavioral treatm ent. Sixteen participants met diagnostic
criteria for other disorders in addition to animal phobia. T hese included another
specific phobia (12); social phobia (six); panic disorder with or w ithout agoraphobia
o r agoraphobia w ithout panic disorder (three); generalized anxiety disorder (two);
m ajor depressive disorder (tw o); obsessive-com pulsive disorder (one); post-traum atic
stress disorder (one); and dysthym ia (one). Six participants m et diagnostic criteria for
m ore than two disorders.
At posttest and one- and three-m onth follow-ups, a m ajority o f the participants
no longer m et diagnostic criteria for the specific treatm ent anim al (see T able 2). W ith
respect to the animal type in general (i.e., other snakes, spiders, etc.), the results are
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m ixed, but not significantly different, betw een the two treatm ent conditions (see
Table 2).

T able 2
Diagnostic Status at Posttest and Follow-up

Full
Criteria

Partial
Criteria

No
Diagnosis

Not
Completed

Posttest - Treatment Animal
Behavioral Treatment

0

3

17

0

Cognitive-Behavioral Treatment

0

4

14

0

One-Month Follow-up —Treatment Animal
Behavioral Treatment

0

2

10

8

Cognitive-Behavioral Treatment

0

1

14

3

Three-Month Follow-up - Treatment Animal
Behavioral Treatment

0

2

7

11

Cognitive-Behavioral Treatment

0

2

8

8

Posttest - General Animal
Behavioral Treatment

3

7

10

0

Cognitive-Behavioral Treatment

1

6

11

0

One-Month Follow-up - General Animal
Behavioral Treatment

1

4

7

8

Cognitive-Behavioral Treatment

0

7

8

3

Three-Month Follow-up - General Animal
Behavioral Treatment

1

5

3

11

Cognitive-Behavioral Treatment

0

4

6

8
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A non-param etric W ilcoxon S igned Ranks T est was com pleted for diagnostic
status. A significant change (j) < .001) w as found from pretest to posttest for both the
specific treatm ent animal and the anim al type in general, indicating that few er
participants

m et diagnostic criteria follow ing

both

behavioral

and cognitive-

behavioral treatm ent. No difference was found betw een the posttest and the follow -up
sessions for either the treatm ent anim al o r the anim al type in general. The diagnostic
status was significantly more severe (g < .01) for the anim al type in general com pared
to the treatm ent anim al at posttest and both follow -up sessions.
F ollow ing treatm ent, no participants m et the full diagnostic criteria for
specific anim al phobia related to the treatm ent anim al including the 17 participants
w ho m et full diagnostic criteria for specific anim al phobia at pretest. O f these 17
participants, three m et partial diagnostic criteria for the specific treatm ent anim al at
posttest, tw o at one-m onth follow -up, and three at three-m onth follow -up. The
rem aining participants who m et full criteria at pretest did not m eet diagnostic criteria
for anim al phobia follow ing treatm ent. A sim ilar pattern em erged fo r the 21
participants w ho m et partial diagnostic criteria at pretest in that four co n tin u ed to
m eet partial criteria for the specific treatm ent anim al at posttest and one at both the
one- and three-m onth follow-ups.
T he results for the general anim al type included three participants m eeting full
diagnostic criteria at posttest and one at each follow -up for those with full criteria at
pretest. O f these 17 participants who m et full criteria at pretest, five m et partial
criteria fo r the general animal type at posttest, eight at one-m onth follow -up, and six
at three-m onth follow-up. For those w ith partial diagnostic criteria at pretest, one m et
full criteria and eight met partial criteria related to the general anim al at posttest, and
three continued to m eet partial criteria fo r both follow -up sessions.
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T reatm ent Effects
F or the behavioral treatm ent condition, 17 o u t o f 20 participants m et the
term inal criteria for success (i.e., com pleted all steps with little or no anxiety
including holding the anim al for at least 60 seconds), and 14 out o f 18 participants in
the cognitive-behavioral treatm ent met terminal criteria for success. One participant
in each treatment condition com pleted all treatm ent steps except picking up the
anim al. The rem aining five participants reached the th ree hour treatm ent session tim e
lim it. One other participant also used the entire three hours for treatm ent, but was able
to com plete the final step with minimal anxiety. A nother participant asked to
term inate treatment follow ing an extreme reaction and was excluded from the
rem ainder of the study. This participant received the behavioral treatm ent procedure.
Several significant differences were found b etw een participants who fully
com pleted and those that partially com pleted treatm ent. T he baseline m easure
differences included: T hought Checklist-N egative (p < .05), C SA Q -C ognitive (p <
.05), CSA Q -Som atic (p < .05), B A T Distance (p < .01 for both trial one and trial
tw o), Therapist R ating o f Phobia Severity (p < .05), Participant Rating o f Phobia
Severity (p < .01), and C SA Q -B A T Cognitive (p < .05). A ll differences involved the
partial completers having more severe sym ptom s. Full and partial treatm ent
com pleters did not differ on diagnostic status at b aseline or throughout the study.
T hese two groups w ere significantly different for num ber o f treatm ent cycles,
treatm ent duration, all BAT measures follow ing treatm ent, and therapist and
participant ratings o f phobia severity (p < .01 for each). T he C SA Q -B A T cognitive
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and som atic subscales w ere significantly different Q) < .05) fo r both groups as well.
These differences continued through the posttest and follow -up sessions.
All participants m ade statistically and clinically significant progress during the
course o f treatm ent even if the term inal criteria w ere not met. Participants in the
behavioral treatm ent condition utilized an average o f 4.55 treatm ent cycles and the
cognitive-behavioral treatm ent group averaged 3.67 cycles. The average treatm ent
duration for the behavioral treatm ent was 106.25 m inutes and the cognitivebehavioral group was 94.22 m inutes. The difference betw een cycles and duration for
the tw o treatm ent conditions is non-significant. Four o f the behavioral treatm ent
participants (20%) and nine (50% ) o f the cognitive-behavioral treatm ent participants
opted to watch their videotape from the treatm ent session at posttest.
To assess the equivalency o f the dependent m easures at pretest, t-tests were
conducted for the tw o treatm ent groups. The behavioral and cognitive-behavioral
treatm ent groups w ere equivalent on all dependent m easures at pretest.

Prim ary Analyses
T reatm ent O utcom es
A repeated m easures analysis o f variance w as co n d u cted on the baseline,
treatm ent (for BA T m easures), posttest, and follow-up scores fo r the tw o treatm ent
conditions on each dependent measure. Table A (see A ppendix J) displays the group
m eans and standard deviations across sessions for each dependent m easure.
For each o f the dependent m easures, the d ata w ill be presented first
graphically in figures for visual inspection. Follow ing the visual analysis, an
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appropriate statistical analysis will be described and displayed in table form .
Figure 2 displays the group m ean changes from baseline through three-m onth
follow -up for the FSS specific anim al item . T he perform ance o f a non-phobic control
group (data from Koch et al., 1998) is also included in the graph fo r com parison.
U pon visual inspection, the tw o groups show a reduction over tim e. T he statistical
analysis confirm ed that both treatm ents produced significant im provem ents from
pretest to posttest (p < .01). The treatm ent effects were m aintained through the
follow -up period (see Table 3) w ith no difference betw een the p o sttest and follow -up
sessions for either treatment. Both treatm ents resulted in significant im provem ents,
and no differences between the treatm ent groups and no interactions w ere found.
6
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Non-Phobic Group

■Behavioral Treatment
•Cognitive Behavioral Tr ea tm ent
Baseline

Posttest

1 - M o n t h Follow- 3 - M o n t h Followup
up

Session

Figure 2.

Fear Survey Schedule —C hange in G roup M eans A cross Sessions.

A sim ilar pattern was found fo r the FSS sm all animal phobia factor com posite
score in that the factor score reduced ov er tim e (p < .01) w ithout any differences
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betw een the two treatment conditions o r any interactions. The significant change
occurred betw een the baseline and posttest sessions for both treatm ents. An additional
change betw een the posttest and the first follow -up session occurred fo r the
behavioral treatm ent condition only resulting in further im provem ent at the onem onth follow -up. The effects from treatm ent w ere m aintained throughout the follow up period. A significant difference (£ < .05) betw een the two treatm ent conditions
w as evident when comparing the baseline and posttest data only in that the behavioral
treatm ent condition had higher (i.e., m ore fearful) scores.

T able 3
Fear Survey Schedule R esults for Repeated-M easures A N O V A

Source

SS

dF

MS

F

Sig.

.775

1

.775

.313

.583

42.168

17

2.480

20.116

2.078

9.679

12.393

.000

.736

2.078

.354

.454

.646

27.594

35.329

.781

B etw een Subjects
Groups
Error
W ithin Subjects
Trials
T rials x Groups
Error

T he specific phobia questionnaire total score group means across all sessions
are displayed in Figure 3 along w ith the non-phobic group com parison. U pon visual
inspection, the tw o treatments show a reduction over time. The statistical analysis
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confirm ed that both treatm ents produced significant im provem ents across sessions (£
< .01) as well as a significant interaction (£ < .05), w hich occurred between the tw o
follow -up sessions (see Table 4). The treatm ent effects were m aintained through the
follow -up sessions w ith no difference betw een the posttest and follow-up sessions for
either treatm ent. Both treatments resulted in significant im provem ents and no
differences betw een the groups were found. V isually, the difference between the tw o
groups at the three-m onth follow-up appears significant; how ever, this difference is
not statistically significant.

25
Behavioral Treatm ent
Cognitive Behavioral Treatm ent
20

a
o
° 15
CO
«
o
ta 10
CL
CO

Non-Phobic Group

Baseline

Posttest

1-Month Follow- 3-Month FollowSession

Figure 3.

UP

UP

Specific Phobia Q uestionnaire - C hange in G roup M eans Across
Sessions.

F or the specific phobia questionnaire, the vigilance and preoccupation
subscales significantly changed over tim e (£ < .05 and g < .01 respectively) as a result
o f treatm ent, with no difference between the treatm ent conditions and no interaction
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effects. This change was m aintained throughout the follow-up w ith no difference
betw een posttest and follow -up sessions. T he avoidance and cognitive-behavioral
subscales also changed significantly over tim e (p> < .01 for both) w ith no difference
betw een the two treatm ent conditions. H ow ever, the change was significant betw een
the baseline and posttest sessions. T he avoidance subscale show ed a significant
interaction between the tw o follow -up sessions (2 < .05) with a repeated-m easures
A N O V A on these two sessions only. T he cognitive-behavioral item subscale show ed
a significant overall interaction (2 < -05) w hich occurred betw een the baseline and
posttest sessions. An additional change over tim e was found between the p o sttest and
follow -up sessions (2 < .05) w hen a repeated-m easures A N O V A was co m p leted for
these sessions only.

T able 4
Specific Phobia Q uestionnaire R esults for R epeated-M easures A N O V A

Source

SS

dF

MS

F

Sig.

14.601

1

14.601

.086

.773

2722.969

16

170.186

324.202

2.050

158.126

16.979

.000

62.758

2.050

30.609

3.287

.049

305.506

32.804

9.313

B etw een Subjects
Groups
Error
W ithin Subjects
Trials
T rials x Groups
Error
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Figure 4 displays the g roup m ean changes from baseline through three-m onth
follow -up for the T hought C h eck list negative items. Upon visual inspection, the two
groups show a substantial change ov er tim e. The statistical analysis confirm ed that
treatm ent produced significant im provem ents over tim e (£ < .01) w ith no differences
betw een the two treatm ent co nditions and no interaction effects (see T able 5). The
baseline and treatm ent T hought C hecklist negative item s w ere equivalent, which
indicates that the participants engaged in their baseline level o f negative thoughts
during the treatment session. T he significant reduction in negative thoughts occurred
betw een

the treatm ent and

po sttest sessions. These effects

w ere

m aintained

throughout the follow -up sessions w ith no difference betw een the tw o treatm ents.
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Behavioral Treatm ent
Cognitive Behavioral Trea tm en t
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13
11
g
7
5
3

Baseline

Treatm ent

P osttest

1-M onth
Follow-u p

3-M onth
Follow-up

Session

F igure 4.

Thought C hecklist (N egative) - Change in G roup M eans A cross
Sessions.

T he Thought C hecklist p ositive item s did not show a significant change over
tim e, but an overall significant difference betw een the tw o treatm ent conditions was
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found (2 < .05). No differences w ere found between the baseline, posttest, and followup sessions. A significant change occurred during the treatm ent session only in that
participants had a greater am ount o f positive thoughts during treatm ent (2 < .05) than
at any other time with no differences between the two treatm ent conditions. A
significant difference was found betw een the two groups w ith a repeated-m easures
A N O V A on the posttest and follow -up sessions only w here the participants in the
cognitive-behavioral treatm ent condition endorsed more positive thoughts, than the
behavioral treatm ent group, during the three-m onth follow-up session (2 < .01).

Table 5
T hought Checklist (N egative) R esults for R epeated-M easures A N O V A

Source

SS

dF

MS

F

Sig.

40.850

1A

40.850

.459

.509

1336.044

15

89.070

691.852

2.937

235.581

11.088

.000

69.123

2.937

23.537

1.108

.355

935.983

44.052

21.247

B etw een Subjects
Groups
Error
W ithin Subjects
Trials
T rials x Groups
Error

Figure 5 shows the group m ean changes from baseline through follow -up for
the C SA Q -C ognitive subscale. V isual inspection shows a reduction in the tw o groups
over tim e. The statistical analysis confirm ed that both treatm ents produced significant
im provem ents in cognitive sym ptom s from pretest to posttest and through follow-up
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(p < .01) (see Table 6). N o differences were found betw een the posttest and follow -up
sessions for either treatm ent condition. B oth treatm ents resulted in significant
im provem ents and no differences betw een the treatm ent groups and no interactions
w ere found.

Behavioral Treatm ent
v 20
O
o
CO
<D

Cognitive Behavioral Treatm ent
-

>

c
U)
o
o
O

<

CO

o

Baseline

Figure 5.

Posttest

1-Month Follow- 3-Month Follow-

C ognitive-Som atic A nxiety Q uestionnaire (C ognitive Subscale) Change in G roup M eans Across Sessions.

The same pattern was found for the C SA Q -Som atic subscale (Figure 6).
V isual inspection dem onstrates a reduction in the two treatm ent groups over time.
The statistical analysis confirm ed that a significant change occurred betw een the
baseline and posttest sessions (p < .01). The treatm ent effects were m aintained
through the follow-up periods (see Table 7) w ith no differences between the posttest
and follow -up sessions. B oth treatm ents resulted in significant im provem ent w ith no
differences betw een the treatm ent groups and no interactions.
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Table 6
Cognitive-Somatic Anxiety Questionnaire (Cognitive Subscale)
Results for Repeated-Measures ANOVA

SS

dF

MS

F

Sig.

G roups

19.477

1

19.477

.588

.454

E rror

562.681

17

33.099

Trials

288.762

1.896

152.270

10.626

.000

Trials x G roups

38.814

1.896

20.468

1.428

.254

Error

461.975

32.238

14.330

Source

B etw een Subjects

W ithin Subjects
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Behavioral Treatm ent
20
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Figure 6.

Posttest

1-Month Follow- 3-Month Follow-

C ognitive-Som atic A nxiety Q uestionnaire (Som atic Subscale) —C hange
in G roup M eans Across Sessions.
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Table 7
Cognitive-Somatic Anxiety Questionnaire (Somatic Subscale)
Results for Repeated-Measures ANOVA

Source

SS

dF

MS

F

Sig.

10.658

1

10.658

.199

.661

912.000

17

53.647

Trials

280.456

2.071

135.409

13.025

.000

Trials x G roups

51.824

2.071

25.022

2.407

.103

E rror

366.044

35.210

10.396

B etw een Subjects
G roups
E rror
W ithin Subjects

Figure 7 displays the group m ean changes from baseline through three-m onth
follow -up for the BAT distance and a com parison with non-phobic performance.
U pon visual inspection, the tw o groups show a dram atic increase over time. The
statistical analysis confirm ed that both treatm ents produced significant im provem ents
from pretest through follow -up (p < .01) with no difference betw een the two
treatm ents and no interaction effects (see Table 8). A significant increase in distance
(p < .01) occurred between baseline and the post-treatm ent as well as for baseline to
posttest (p < .01). A significant decrease in distance (p < .01) occurred betw een the
post-treatm ent and posttest scores. No differences were found betw een the posttest
and follow -up sessions.
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Session

Figure 7.

3-Month
Follow-up

B ehavior A voidance T est D istance - Change in G roup M eans Across
Sessions.

Table 8
B ehavior A voidance Test D istance R esults for R epeated-M easures A N O V A

Source

SS

dF

MS

F

Sig.

44.669

1

44.669

.436

.518

1742.320

17

102.489

4731.300

1.912

2474.546

128.597

.000

1.447

1.912

.757

.039

.957

625.458

32.504

19.243

B etw een Subjects
G roups
Error
W ithin Subjects
Trials
Trials x G roups
Error
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The group m eans change over tim e is displayed in Figure 8 for B A T co n tact
tim e. A dram atic increase is seen across sessions. The statistical analysis co n firm ed
that both treatm ents produced significant im provem ents from pretest through the
follow -up sessions (£ < .01) w ithout any differences betw een the two treatm ent
conditions or any interaction effects (see T able 9). A significant increase o ccurred
betw een pretest and post-treatm ent (£ > .01) and pretest and posttest (jo < .01). A
significant decrease was found betw een post-treatm ent and posttest (jo < .01). N o
differences w ere found betw een the posttest and follow -up sessions.
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F igure 8.

B ehavior Avoidance Test C ontact —C hange in G roup M eans A cross
Sessions.
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Table 9
Behavior Avoidance Test Contact Results for Repeated-Measures ANOVA

Source

SS

dF

MS

F

Sig.

2200.964

1

2200.964

.171

.684

218674.320

17

12863.195

333162.149

2.119

157244.226

51.979

.000

4138.149

2.119

1953.103

.646

.539

108961.724

36.019

3025.130

B etw een Subjects
G roups
E rror
W ithin Subjects
Trials
T rials x G roups
E rror

Figure 9 displays the group mean changes from baseline through follow -up for
the B A T m axim um stopping point SUDS level. U pon visual inspection, the tw o
g ro u p s show a reduction over time. T he statistical analysis confirm ed that both
treatm ents produced significant im provem ents from baseline through follow -up (p <
.01) w ithout any differences betw een the two treatm ent conditions and no interaction
effects (see T able 10). A significant decrease occurred betw een baseline and treatm ent
(g < -01) and betw een baseline and posttest (p < .01). A significant increase w as
fo u n d betw een treatm ent and posttest (p < .01). A significant change over tim e (p <
.05) w as observed w ith a repeated-m easures A N O V A conducted on the posttest and
fo llo w -u p sessions. T he behavioral treatm ent group decreased their SUDS from
p o stte st to both follow -up sessions and the cognitive-behavioral treatm ent group
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SU D S levels increased slightly from posttest to one-m onth follow -up and then
reduced between the two follow -up sessions.
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Figure 9.

B ehavior A voidance Test Subjective Units o f D istress - C hange in
Group M eans A cross Sessions.

Figure 10 displays the group mean changes from baseline for the SUDS level
at the B A T baseline stopping point throughout the sessions. V isual inspection shows
a dram atic decrease in the baseline SUDS level across sessions. The statistical
analysis confirm ed that both treatm ents produced significant im provem ents from
pretest through follow-up sessions (£ < .01) w ith no differences betw een groups and
no interaction effects (see T able 11). The significant change occurred between the
baseline and treatm ent sessions. The changes were m aintained through the posttest
and follow -up sessions w ithout any differences between the tw o treatm ent conditions.
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Table 10
Behavior Avoidance Test Subjective Units of Distress
Results for Repeated-Measures ANOVA

SS

dF

MS

F

Sig.

G roups

2192.854

1

2192.854

1.835

.193

E rror

20318.578

17

1195.210

27453.946

2.009

13666.691

28.823

.000

854.157

2.009

425.203

.897

.418

16192.622

34.150

474.162

Source

Between Subjects

W ithin Subjects
Trials
Trials x G roups
E rror
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Figure 10.

1-Month
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3-Month
Follow-up

B ehavior A voidance T est B aseline Subjective U nits o f D istress C hange in G roup M eans A cross Sessions.
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Table 11
B ehavior A voidance Test B aseline Subjective U nits o f D istress
R esults for R epeated-M easures A N O V A

SS

dF

MS

F

Sig.

G roups

683.337

I

683.337

1.360

.262

Error

7538.686

15

502.579

38606.943

1.329

29052.338

67.377

.000

223.743

1.329

168.371

.390

.598

8594.939

19.933

431.189

Source

B etw een Subjects

W ithin Subjects
Trials
T rials x G roups
Error

Figure 11 displays the group m ean changes from baseline through follow -up
for the T herapist R ating o f Phobia Severity scale including a non-phobic com parison.
V isual inspection indicates a significant decrease over time. The statistical analysis
confirm ed that both treatm ents produced significant im provem ents across sessions (p
< .01) w ith no differences betw een the two treatm ent conditions and no interaction
effects (see Table 12). The significant change occurred betw een the baseline and
treatm ent sessions. The changes were m aintained through the posttest and follow -up
sessions w ithout any differences betw een the tw o treatm ent conditions.
T he changes across sessions for the Participant R ating o f P h o b ia Severity
scale are displayed in Figure 12. Upon visual inspection, the two groups show a
reduction over time. The statistical analysis confirm ed that both treatm ents produced
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significant im provem ents across sessions (p < .01) w ithout any differences betw een
the treatm ent conditions and no interaction effects (see T able 13). The significant
change occurred betw een the baseline and treatm ent sessions, and this change was
m aintained through the posttest and follow -up sessions.
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T herapist Rating - C hange in G roup M eans A cross Sessions.

Pearson’s correlation coefficients were com puted to assess the relationship
betw een the therapist and participant ratings across sessions. The therapist and
participant ratings w ere significantly correlated during the baseline, treatm ent, onem onth follow -up, and three-m onth follow -up fo r the treatm ent animal (for all p <
.01). In addition, the two ratings at posttest and three-m onth follow-up for the non
treatm ent anim als w ere significantly related (for both p < .05). The therapist and
participant ratings w ere all significantly correlated.
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Table 12
T herapist R ating R esults for R epeated-M easures A N O V A

Source

SS

dF

MS

F

Sig.

.278

1

.278

.109

.745

40.711

16

2.544

34.044

2.606

13.062

18.884

.000

1.111

2.606

.426

.616

.586

28.844

41.702

.692

Between Subjects
Groups
Error
W ithin Subjects
Trials
Trials x Groups
Error
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Figure 12.

Participant R ating - C hange in Group M eans A cross Sessions.
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Table 13
Participant R ating R esults for R epeated-M easures A N O V A

Source

SS

dF

MS

F

Sig.

1.241

1

1.241

.548

.469

38.464

17

2.263

17.967

2.988

6.013

9.315

.000

.662

2.988

.221

.343

.794

32.791

50.797

.646

B etw een Subjects
G roups
E rror
W ithin Subjects
Trials
Trials x G roups
Error

Figure

13 displays

the

group mean

changes

across

sessions

for the

p articipant’s rating on the Expected Success o f T reatm en t scale. U pon visual
inspection, the two groups show a small increase over tim e. T he statistical analysis
confirm ed that both treatm ents produced significant im provem ents from pretest to the
rem aining sessions (p < .01) w ithout any difference betw een the treatm ent conditions
and no interaction effects (see Table 14). The treatm ent effects w ere m aintained
throughout the posttest and follow-up sessions. A repeated-m easures ANOVA
conducted between the baseline and posttest sessions only an d the posttest and onem onth sessions only indicates a significant interaction (p < .05 for both).
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F igure 13.

Expected Success o f T reatm ent - Change in G roup M eans Across
Sessions.

Table 14
Expected Success o f T reatm ent R esults for R epeated-M easures A N O V A

SS

dF

MS

F

Sig-

1.741

1

1.741

.380

.546

77.964

17

4.586

Trials

7.455

2.604

2.863

6.696

.001

Trials x G roups

2.739

2.604

1.052

2.460

.083

18.924

44.266

.428

Source

B etw een Subjects
G roups
Error
W ithin Subjects

E rror
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The C SA Q

C ognitive specifically for the B A T show ed a significant

im provem ent over tim e (p < .01) with no differences betw een treatm ent conditions
and no interaction effects. The significant change occurred betw een baseline and
treatm ent. A n additional significant (p < .05) change was seen betw een the posttest
and the follow -up sessions with a repeated-m easures A N O V A that included only the
posttest and follow -up data. A decrease occurred between the posttest and one-m onth
follow -up sessions. The sam e effects were seen for the C SA Q -B A T Som atic scale in
th at a significant change (p < .01) occurred across sessions w ithout any differences
found betw een the treatm ent conditions and no interaction effects. T he significant
change occurred betw een the baseline and treatment sessions w ith another significant
change (p < .01) betw een the posttest and one-m onth follow -up sessions. No
differences w ere found betw een the two follow-up sessions.

G eneralization Effects
A R epeated-M easure A N O V A was com pleted to assess the effects related to
the generalization condition for each dependent measure. Because the generalization
condition was not im plem ented until after the posttest session, this involved the
posttest (pretest data for generalization conditions) and both follow -up sessions. N o
significant differences over time, differences between groups, and no interaction
effects w ere found for a m ajority o f the measures. However, the few significant
differences that w ere found included the SPQ Vigilance subscale, SPQ C ognitiveB ehavioral item s, C SA Q -B A T Som atic scale for both the treatm ent and other
anim als, and SU DS for the treatm ent anim al. For the SPQ V igilance subscale, the
generalization condition show ed betw een group differences (p < .05), betw een the
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tw o follow -up sessions and an interaction effect betw een the posttest and one-m onth
follow -up (p < .05 for both). Participants in the generalization condition increased in
vigilance through the follow-ups w hile the non-generalization participants decreased
their level o f vigilance over time. The SP Q C ognitive-B ehavioral item s show ed a
significant decrease over tim e (p < .05) and the non-generalization condition
produced slightly greater reductions. The C SA Q -B A T Som atic scale for the treatm ent
anim al also show ed a significant reduction over tim e (p < .01), betw een the posttest
and

one-m onth

follow-up

sessions,

and

the

reduction

was

greater

for

the

generalization condition. The C SA Q -B A T Som atic scale for the other (non-treatm ent)
anim als dem onstrated a significant reduction (p = .01) between the tw o follow -up
sessions for both groups, with a slightly greater decrease for the generalization
condition. N o differences were found on the C SA Q -B A T C ognitive scale for the
o ther anim als or the therapist and participant ratings o f phobia severity for the other
anim als betw een generalization conditions, tim e and no interaction effects. T he SU D S
for the treatm ent animal also show ed a significant reduction across sessions (p < .05).
T his change was greater for the generalization condition.
F or the 19 participants in the generalization condition, O ne-W ay A N O V A s
w ere com pleted w ith each m easure to determ ine if differences existed for those w ho
did not com plete any generalization sessions com pared to participants w ho com pleted
either one or all three generalization sessions. The four participants w ho did not
com plete any generalization sessions received the behavioral treatm ent. Participants
w ho com pleted all three generalization sessions had significantly m ore severe phobia
(less individuals w ith partial phobia criteria) (p < .05) at pretest than those that
com pleted

only

one generalization

session.

The

phobia

diagnosis
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was

not

significantly different for those that did not com plete any generalization sessio n s
com pared to those that com pleted one or three sessions. The participants w ho
com pleted all three generalization sessions also endorsed significantly m ore item s on
the baseline SPQ C ognitive-B ehavioral subscale com pared to those that only
com pleted one session o f generalization (p < .05). T hose participants who d id not
com plete any generalization sessions had a significantly greater am ount o f n eg ativ e
thoughts from the Thought C h eck list during treatm ent (p < .05) com pared to those
that com pleted all the generalization sessions. In addition, the participants w h o did
not com plete any generalization sessions rated the treatm ent as significantly m ore
intrusive com pared to those that com pleted one or three generalization sessions (2 <
.05 for both). The participants w ho com pleted all three generalization sessions
indicated that they experienced significantly less distress during the treatm ent
com pared to those that com pleted one or no generalization sessions (p < .05 for both).
N o other differences between these three groups w ere significant.

Interaction Between Treatm ent and G eneralization C onditions
A 2 x 2 repeated-m easures A N O V A was com pleted with the two treatm en t
and tw o generalization conditions. The overall w ithin-subjects interaction was
significant for contact (p < .05). T he overall betw een-subjects interaction was
significant for contact (p < .05) and therapist rating o f phobia severity (p < .05).
Figure 14 displays the co n tact tim e for the four treatm ent and generalization
groups. T he w ithin-subjects interaction for contact was significant betw een b aselin e
and treatm ent (p < .05), baseline and posttest (p < .05), and betw een baseline,
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posttest, and one-m onth follow -up (2 < .05). The betw een-subjects interaction for
contact w as significant betw een baseline and treatm ent (2 < .05), baseline and posttest
(2 < -05), treatm ent to posttest (2 < -01), posttest and one-m onth follow-up (2 < .05),
one-m onth to three-m onth follow -ups (2 < .01), and betw een posttest and both
follow -ups (2 < -05), and pretest, posttest, and one-m onth follow -up (2 < .05). T he
behavioral,

non-generalization

and

cognitive-behavioral,

generalization

groups

consistently held the anim al longer than the cognitive-behavioral, non-generalization
and behavioral, generalization groups across all sessions. H ow ever, these four groups
were not significantly different from one another.
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B e h a v i o r a l T r e a t m e n t - No n- Ge n e r a l i z a t i o n
Behavioral Treatment - Generalization
C o g n i ti v e- B eh av i o ra l T r e a t m e n t - N o n- G en er a li za ti o n
C o g n i ti v e- B eh av i o ra l T r e a t m e n t - G ener al i za ti on_____
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Figure 14.

T reatment

Posttest
Session

1-Month
Follow-up

3-Month
Follow-up

B ehavior A voidance T est Contact Tim e - C hange in G roup M eans
A cross Sessions for A ll Conditions.

F igure 15 show s the changes in therapist rating for phobia severity across
sessions fo r the generalization and treatment conditions. A long with the significant
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overall betw een-subjects interaction, a significant interaction occurred betw een
baseline and posttest (2 < .05), treatm ent and posttest (2 < .05), posttest and onem onth follow -up (2 < .05), one-m onth and three-m onth follow -up (2 < .05), posttest
and two follow -up sessions (2 < .05), and baseline, posttest and one-m onth follow -up
(2 < .05). C onsistent w ith contact times, the therapist ratings were less severe for the
cognitive-behavioral, generalization and the behavioral, non-generalization conditions
and more severe for the cognitive-behavioral, non-generalization and the behavioral,
generalization groups. T hese four groups w ere not significantly different from one
another.

5

Behavioral Treatment - Non-Generalization
Behavioral Treatment - Generalization
Cognitive-Behavioral Treatment - Non-Generalization
Cognitive-Behavioral Treatment - Generalization____

0
Baseline

Figure 15.

Treatment

Posttest
Sessions

1-Month
Follow-up

3-Month
Follow-up

T herapist R ating —Change in G roup M eans A cross Sessions for All
C onditions.

The changes over time for the treatm ent and generalization conditions are
show n in Figure 16 for the Behavioral A voidance T est D istance scores. A w ithin-
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subjects interaction was found betw een the posttest and tw o fo llo w -u p sessions (p <
.01) for the distance score. B etw een-subjects interaction effects w ere significant
betw een baseline and posttest (p < .05), treatm ent and posttest (p < .05), posttest and
one-m onth follow -up (p < .05), one- and three-m onth follow -ups (p < .05), and
baseline, posttest, and one-m onth follow -up ( p < .05). A gain the cognitive-behavioral,
generalization and behavioral, non-generalization conditions sh o w ed greater BA T
distance com pared to the cognitive-behavioral, non-generalization and behavioral,
generalization conditions for both the w ithin- and betw een-subject interactions. These
fo u r groups were not significantly different from one another.

0 J-------------Baseline

F igure 16.

Behavioral Treatment - Non-Generalization
Behavioral Treatment - Generalization
Cognitive-Behavioral Treatment - Non-Generalization
Cognitive-Behavioral Treatment - Generalization____
... , _
,
I
Treatment
Posttest
1-Month
3-Month
Sessions
Follow-up
Follow-up

B ehavior A voidance T est D istance - C hange in G ro u p M eans Across
Sessions for A ll C onditions.

A dditional w ithin- and betw een-subject interactions w ere fo u n d for the groups
w hen the overall interactions across all sessions were not significant. This included
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w ithin-subject interactions from posttest to the two follow -up co n d itio n s for the FSS
F actor and Thought C hecklist N egative (p < .05 for both). F or both o f these, the
behavioral, generalization

h ad m ore severe scores, but the

groups w ere not

significantly different. Significant betw een-subjects interactions w ere found for
C SA Q -B A T Cognitive and B aselin e SUDS (p < .05 for each) fo r the treatm ent and
posttest sessions. The cognitive-behavioral, generalization an d behavioral, non
generalization

groups

perform ed

better

than

the

cognitive-behavioral,

non

generalization and the behavioral, generalization conditions fo r both o f these
m easures. The behavioral, non-generalization condition had a sig n ifican tly lower
B aseline SUD S rating than the cognitive-behavioral, non-generalization group at the
treatm ent session. No other significant differences were found betw een the four
groups for C SA Q -B A T C ognitive or Baseline SUDS across sessio n s. A withinsubjects interaction w as found betv/een posttest and one-m onth follow -up for the
C SA Q -C ognitive subscale (p < .05). Again, the cognitive-behavioral, generalization
group had the lowest scores and the behavioral, generalization condition had the
highest scores. No significant differences between the four groups w ere found on this
m easure.
N o significant differences w ere found between the fo u r groups for any
baseline m easure. The behavioral, non-generalization group had a significantly lower
(p < .05) baseline SUDS

score com pared to the cognitive-behavioral,

non

generalization group during the treatm ent session. For the second B A T trial C ontact
score, the behavioral, non-generalization group was significantly higher than the
behavioral, generalization and the cognitive-behavioral, non-generalization groups (p
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< .05 for both) at posttest. The cognitive-behavioral, non-generalization group
reported significantly (£ < .05) m ore distress during the treatm ent session than the
cognitive-behavioral, generalization group. In addition, both the behavioral, non
generalization and the cognitive-behavioral, non-generalization groups reported that
the treatm ent condition was significantly m ore intrusive (2 < .01 and £ < .05,
respectively) com pared to the cognitive-behavioral, generalization condition. A
significant difference was found for the SPQ V igilance subscale at both follow -up
sessions. For the one-m onth follow -up, the behavioral, generalization condition was
significantly w orse than the three other groups (£ < .01 for com parison w ith
behavioral, non-generalization and cognitive-behavioral, non-generalization and £ <
.05 for cognitive-behavioral, generalization). A t the three-m onth follow -up, the
behavioral, generalization group rem ained significantly w orse than the cognitivebehavioral, non-generalization group (£ < .05) on the SPQ Vigilance subscale. No
oth er significant differences were found betw een the four groups.

A dditional A nalyses
Effect Size
T reatm ent effect sizes were com puted w ith G lass’s Delta:

(M

- M

).

rs ^prcT

T he pretest standard deviation for contact was 0, so the posttest standard deviation
w as used for contact scores. T he overall effect sizes w ere averaged for behavioral,
self-report, and subjective rating m easures. T able 15 depicts the effect sizes for each
treatm ent condition. The effect sizes for behavioral m easures ranged from 1.35 for
contact and 3.26 for distance for the behavioral treatm ent and 1.58 for contact and
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2.95 for distance for the cognitive-behavioral treatm ent. F o r the behavioral treatm ent,
the SPQ -C ognitive-B ehavioral items had the low est effect size at 0.05 and fo r the
cognitive-behavioral treatm ent the TC positive had the low est effect size at 0.34. For
both treatm ent conditions, the FSS Animal had the largest effect size at 1.30 and 1.31
for the behavioral and cognitive behavioral treatm ents respectively. Expected success
o f treatm ent was the low est effect size for the behavioral treatm ent at 0.53 an d the
SU DS was the low est for the cognitive-behavioral treatm ent at 1.00. F o r both
treatm ent conditions, the B aseline SUDS was the largest effect size with 2.21 and
1.70 for the behavioral and cognitive-behavioral treatm ents, respectively.

Table 15
T reatm ent Effect Sizes A cross M easures

Behavioral T reatm ent

C ognitive-B ehavioral
T reatm ent

Behavioral M easures

2.25

1.96

Self-Report M easures

0.76

0.87

Subjective Ratings

1.43

1.31

Trial T w o B A T M easures
The percentage o f participants that choose to com plete a second trial o f the
B A T are listed in T able 16 across sessions. Paired Sam ples T-Tests were com puted
for the differences betw een trial one and trial tw o on the BAT m easures. T h e only
significant difference was the distance m easure at baseline, w hich increased
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significantly (p < .01) from trial one to trial two. U tilizing the second trial distance
score did not produce any differences com pared to the repeated-m easures ANOVA
com pleted for the trial one distance value. A com parison betw een the two treatm ent
and generalization conditions for the second trial B A T found significant interactions
for contact betw een baseline and posttest (p < .01 for both betw een- and withinsubjects) and betw een treatm ent and posttest (p < .01 for betw een-subjects), and
distance betw een treatm ent and posttest (p < .01 for both w ithin- and betweensubjects). The cognitive-behavioral, generalization and behavioral, non-generalization
conditions had m ore contact and distance than the cognitive-behavioral, non
generalization and behavioral, generalization groups. A t posttest, the behavioral, non
generalization condition had significantly m ore co n tact tim e com pared to the
behavioral, generalization and the cognitive-behavioral, non-generalization groups (p
< .05 for both). No oth er differences were found betw een these four groups. No
significant interactions were found across all sessions fo r any trial two BAT
measures.
BA T O vert R esponses
Participant overt responses were recorded during the B A T assessm ents. The
overt responses included shaking/trem bling, crying/eyes w atering, holding self, and
turning w ay/not looking. A dram atic reduction w as found in turning aw ay/not looking
w ith 16 participants displaying this behavior at baseline; and only two following
treatm ent, and three at posttest. Holding self reduced from seven to three, to one
across sessions. C rying/eyes w atering also reduced fro m six at baseline, to zero
following treatm ent, and one at posttest. O ccurrences o f shaking/trem bling did not
change w ith two, tw o, and three participants engaging in this behavior across
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sessions. This trend continued for each overt behavior during both follow -up sessions
as w ell.

Table 16
Percentage of Participants T hat C om pleted the BAT T rial Tw o A cross Sessions

Behavioral T reatm ent

C ognitive-B ehavioral
T reatm ent

B aseline

45%

39%

T reatm ent

45%

44%

Posttest

55%

39%

O ne-M onth Treatm ent Anim al

17%

13%

O ne-M onth Animal 2

18%

21%

O ne-M onth Animal 3

20%

23%

T hree-M onth Treatm ent A nim al

56%

30%

T hree-M onth Animal 2

37%

30%

T hree-M onth Animal 3

33%

30%

A dditional A nim als for B A T Follow -up A ssessm ents

D uring the first follow -up B A T assessm ent, 88.5% o f the participants initially
selected the treatm ent animal follow ed by the other two anim als. F or the three-month
follow -up, 68.4% o f the participants selected the treatm ent anim al first. A ccording to
a K ruskal-W allis N on-Param etric Test, no differences w ere found betw een the two
treatm ent and two generalization conditions related to the o rd er o f anim al selection.
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T he differences betw een the m easures for the treatm ent anim al and the other
anim als w ere com pared using a Paired Sam ples T-Test. The therapist and participant
ratings for the treatm ent anim al were significantly different from ratings for the other
anim als at both follow-up sessions (p < .01 for all four com parisons). In addition, the
C SA Q -B A T cognitive and som atic scales for the treatm ent animal were significantly
different from the C SA Q -B A T other cognitive and som atic subscales at the onem onth follow -up (p < .05 for cognitive and p < .01 for som atic). A lso, the threem onth follow -up approached significance. The ratings and scales for the other
anim als w ere more severe than for the treatm ent animal in all cases.
A repeated-m easures A N O V A fo r the generalization and treatm ent conditions
resulted in significant w ithin-subject interaction effects between the tw o follow -up
sessions for the Therapist R ating o f O ther A nim al Severity (p < .05) and D istance
Trial O ne A nim al Three (p < .05). On both measures the cognitive-behavioral,
generalization

group

dem onstrated

superior

perform ance

and

the

behavioral,

generalization group showed the poorest perform ance. However, the four groups w ere
not significantly different from one another.

D EV S Items
Independent Sam ples T-Tests w ere conducted on the D EV S

item s. A

significant difference (p < .05) occurred for the intrusiveness o f the treatm ent
procedure overall. The participants in the behavioral treatm ent condition rated the
treatm ent as significantly m ore intrusive com pared to the participants w ho received
the cognitive-behavioral treatm ent. B oth treatm ent groups rated the treatm ent w ithin
the “som ew hat intrusive” range. Participants from both treatm ent conditions rated the
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baseline and treatm ent sessions to be som ew hat distressing, and also indicated that
they w ere not very distressed follow ing the treatm ent session. Both treatm ent groups
rated the treatm ent they received as highly acceptable and they w ould pro b ab ly
recom m end the treatm ent to friends or family m em bers with animal fears.
C ognitive C oping C ard Use
Participants in the cognitive-behavioral treatm ent intervention reported that
they read over or thought about the coping self-statem ents on the card from 1 to 90
m inutes (M = 10.5 m inutes) prior to the treatm ent session. M ost participants ten d ed to
look at the card briefly. D uring the treatm ent session, participants utilized th e card
from a few seconds to throughout the treatm ent. D uring treatment, four p articip an ts
used the card less than 10% o f the time, seven betw een 10-40%, three 50-75% , and
tw o for 75% or greater. M ore use o f the cognitive coping card (greater than 75% )
during treatm ent was related to significantly less d istance and contact tim e at p o sttest
and less distance for the treatm ent animal at the one-m onth follow-up. In add itio n ,
m ore use o f the card was related to significant increases in distress fo llo w in g
treatm ent (i.e., FSS factor score, therapist and participant ratings for the treatm en t
anim al, C SA Q -C ognitive and C SA Q -Som atic for the treatm ent anim al at the onem onth follow -up; and FSS factor score, C SA Q -Som atic, therapist and p articip an t
ratings for the treatm ent anim al, and CSA Q -BA T —Som atic for the treatm ent anim al
at the three-m onth follow-up). U se o f the coping card at least 50% o f the tim e during
treatm ent was related to greater SUDS rating at p o sttest and the three-m onth fo llo w up, greater SPQ Preoccupation and A voidance subscales, C SA Q - Som atic scale, and
greater therapist and participant ratings for phobia severity. Use o f the co g n itiv e card
for at least 75% o f the treatm ent session resulted in a trend o f more treatm ent cycles
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and less distance during the post-treatm ent B A T. Participants who utilized the
cognitive card m ore during treatm ent, were not significantly m ore phobic prio r to or
follow ing treatm ent. H ow ever, m ore use o f the card appears to be related to greater
difficulty w ith treatm ent and m ore severe responses on specific m easures follow ing
treatm ent.

A nim al Interaction Form
G eneralization Session Interactions. The A nim al

Interaction Form

w as

com pleted for the 28 (14 from first generalization session and seven each for the
second and third sessions) generalization sessions com pleted. Participants recorded
infrequent occurrence o f several overt responses for the generalization sessions
including: shaking (7.1% ), crying (0%), holding se lf (10.7% ), turning away (17.9% ),
sw eating (21.4% ), trem bling (17.9% ), eyes w atering (0% ), asking for help (17.9% ),
closing eyes (7.1% ), scream ing (0% ), and other (28.6% ). The rating for com fort w ith
the anim al interaction was very com fortable for 33.3% and som ew hat com fortable for
48.1% o f the participants. For sym ptom severity, 63% o f participants reported being
sym ptom free and 22.2% slightly severe. T he am ount o f distress experienced during
the interaction was none to m inim al for 74.1% o f the participants.
N on-L aboratory Interactions. T w enty-six A nim al Interaction Forms were
com pleted for contact w ith the feared animal outside o f the laboratory setting. T w enty
o f these w ere com pleted at hom e and either m ailed in o r brought to the next session
and six w ere com pleted during a session for a previous interaction. Seven interaction
form s w ere com pleted by three participants in the behavioral - non-program m ed
generalization condition, eight forms by three participants in the behavioral program m ed generalization group, 10 form s by three participants in the cognitive-
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behavioral -

non-program m ed generalization condition and one form from a

participant in the cognitive-behavioral - program m ed generalization group. The
follow ing overt responses w ere recorded for these “hom e” interactions: shaking
(26.9% ), crying (7.7% ), holding self (3.8% ), turning away (50% ), sw eating (11.5% ),
trem bling (23.1%), eyes w atering (7.7%), asking for help (38.5% ), closing eyes
(15.4% ), screaming (3.8% ), and other (46.2% ). The rating for com fort with the anim al
interaction was 30.8% very uncom fortable and 38.5% som ew hat uncom fortable. The
severity of phobia sym ptom s prim arily ranged from sym ptom free (11.5% ), and
slightly severe (38.5% ), to m oderately severe (34.6%). T he average am ount o f
interaction distress fell w ithin the som ew hat distressed range. The am ount of distress
experienced for the next few hours was none to minimal (76% ).
The interaction differences between the generalization session and non
laboratory interactions w ith the feared animals were analyzed w ith an independent
sam ples

t-test.

The

“hom e”

interactions

were

significantly

shorter,

more

uncom fortable, involved m ore severe sym ptom s and resulted in m ore distress during
the interaction (£ < .01 for each o f these).
Clinical Significance
Clinical significance

w as com puted utilizing the

m eans

and standard

deviations for the treatm ent participants and the non-phobic control subjects from a
previous study (Koch et al., 1998) based on the procedure outlined by Jacobson &
R evenstorf (1988). T he cu t-o ff score m ethod was used to classify participants as m ost
likely belonging in the functional or dysfunctional range at baseline and posttest.
Figure 17 shows the percentage o f participants who fell w ithin the non-phobic range
o f functioning both at baseline and posttest across self-report, behavioral, subjective
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ratings, and diagnostic status for all treatm ent participants. Follow ing treatm ent, 82%
o f participants no longer met full o r partial diagnostic criteria for specific phobia
related to the treatm ent anim al and 80% o f participants w ere w ithin the non-phobic
range for their baseline SUDS at posttest. An independent sam ples t-test betw een the
treatm ent and non-phobic control participants indicated that these tw o groups were
not significantly different on the B A T D istance and Baseline SU D S at posttest. The
posttest B A T contact tim e was significantly greater for the treatm ent participants
com pared to the non-phobic control participants. However, the c u t-o ff tim e for the
non-phobic participants (M = 44.73) was 60 seconds; w hereas, the treatm ent
participants (M= 120.97) utilized 180 seconds maximum cu t-o ff tim e fo r holding the
anim al. The non-phobic participants had significantly m ore functional scores on the
rem aining m easures (£ < .01 for each) com pared to the treatm ent participants.
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Intent-to-T reat Analysis
An intent-to-treat analysis was com pleted in which the pretest scores were
carried forw ard to the posttest and follow -up sessions for those p articipants who
com pleted baseline and not treatm ent and those that com pleted the treatm ent session
but not the posttest session. In addition, the previous scores were carried forw ard for
those participants w ho did not com plete the follow -up sessions. T h is allow s these
participants to be included as if they w ould have not im proved based on treatm ent or
additional sessions. This analysis included a m axim um of 23 participants in each
treatm ent group. N o significant differences w ere found betw een the tw o treatm ents on
any m easure. A significant change across tim e (p < .01) occurred fo r all m easures
except for the second trial BA T scores, w hich were non-significant. Therefore,
significant im provem ents were found from treatm ent even when d ro p o u t and non
com pleter participants w ere included in the analysis.
A significant change (p < .01) and im provem ent was found betw een baseline
and treatm ent session data for all m easures except T hought C hecklist N egative, which
im proved significantly between the treatm ent and posttest sessions (p < .01). No
differences w ere found between the treatm ent and posttest sessions for the B aseline
S U D S, Participant R ating of Phobia Severity, Expected Success o f T reatm ent, and the
C SA Q -B A T C ognitive subscale. The T hought C hecklist Positive (p < .01), C ontact (p
< .01), D istance (p < .01), SUDS (p < .01), T h erap ist Rating o f P h o b ia Severity (p =
.01), and C SA Q -B A T Somatic subscale (p < .05) were all worse from the treatm ent to
the posttest sessions. A ll participants show ed significant im provem ents (p < .01 for
all m easures except the CSAQ C ognitive-B ehavioral item s where p < .05) betw een
baseline and posttest on all m easures except the Thought C hecklist P ositive w hich
w as non-significant. T he CSA Q -B A T C ognitive (p < .05) and S om atic (p < .01)
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subscales and the FSS factor (j> < .05) score all im proved significantly from po sttest
to one-m onth follow -up. The scores on the other m easures did not change
significantly betw een the posttest and one-m onth follow -up. No significant changes
w ere seen between the tw o follow -up sessions on any m easure.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER IV
D ISC U SSIO N

C om parison with Previous Research

Consideration o f the M ain H ypotheses
The results o f the present study support previous evidence that one-session
exposure treatm ent had a significant effect on alleviating sym ptom s o f sm all animal
phobia. In addition, this treatm ent was effective for reducing behavioral, cognitive,
and somatic sym ptom s related to the phobia w ith and w ithout the utilization o f a
cognitive treatm ent com ponent. The first hypothesis w as supported in that all
participants show ed dram atic im provem ent in the alleviation o f specific phobia
sym ptoms follow ing both one-session exposure treatm ent procedures. H ow ever, since
the laboratory generalization procedure used in this study did not im prove treatm ent
outcome through the three-m onth follow-up the second hypothesis was not supported.
The significant am ount o f dropout during the follow -up sessions may have prevented
the detection o f any differences based on the generalization condition.
This study utilized a m odified treatment procedure based on O st’s one-session
exposure treatm ent (O st 1997b, 1997a, 1989). This m odified, strictly behavioral,
treatment was also used in Koch et al. (1998). A cognitive com ponent was added to
the present behavioral treatm ent procedure for the cognitive-behavioral one-session
exposure treatm ent, and show ed sim ilar results to O st’s in the alleviation o f specific
phobia sym ptom s. T he tw o treatm ent conditions w ere not significantly different in
83
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term s o f treatm ent duration. H ow ever, the behavioral treatm ent was rated as
significantly m ore intrusive com pared to the cognitive-behavioral treatm ent. B ased on
this, the cognitive-behavioral one-session exposure treatm ent procedure was preferred
by participants over the behavioral one-session exposure treatm ent.
N o m eaningful differences w ere found based on the generalization condition.
H ow ever, a com bination o f the generalization condition and the behavioral treatm ent
resulted in a greater am ount o f dropout during the follow -up sessions. The increased
dem and for additional generalization sessions m ay have reduced p a rticip an t’s
com m itm ent to the com pletion o f the study. Possibly these treatm ent booster sessions
w ere thought to be unnecessary o r too tim e consum ing for the typical college student
schedule. O ver the course o f the tw o studies com pleted w ith the m odified one-session
exposure procedure, som e participants reported generalization o f treatm ent effects to
other types o f the feared animal, w hereas, other participants did not report such
generalization. This study attem pted to im prove treatm ent generalization through
additional exposure to the treatm ent and other anim als w ithin a controlled laboratory
setting w ithout success. Perhaps future studies should assess the effectiveness o f non
laboratory based generalization.
A nother factor that may have contributed to generalization, was the type o f
treatm ent anim al utilized. This seem ed particularly true for spider treatm ent (m ost
frequently selected am ong participants) w here the participants interacted w ith a rosehair tarantula. Participants w ould not encounter this anim al w ithin th eir natural
environm ent and the typical house sp id er behaves differently from the taran tu la (e.g.,
m oves quickly and som etim es unpredictably). The use o f up to three generalization
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sessions did not im prove the p articip an t’s com fort w ith handling house an d w o lf
spiders. Initially, the rose-hair tarantula w orks w ell for treatment because o f its
predictability; how ever, perhaps prior to term inating treatm ent the participant should
interact w ith other types o f the feared anim al that are found in his o r h er natural
environm ent. This change m ay serve to im prove treatm ent effectiveness and
generalization.
In addition, the use o f a controlled laboratory setting with the feared anim al in
an enclosed cage m ay reduce generalization to settings w here contact with the feared
anim al is uncontrolled and unpredictable. A lso, in the natural environm ent an
assistant w ould not be available to help the participant in the case o f an em ergency.
H ow ever, despite the use o f a controlled laboratory setting, many participants no
longer m et diagnostic criteria for the feared anim al at posttest and follow-up.

C onsideration o f the Outcom e M easures
T h e findings in the present investigation w ith respect to the BA T and the selfreport m easures o f fear were consistent w ith the results o f previous studies (K och et
al., 1998; H ellstrom & Ost, 1995; O st et al., 1992; O st et al., 1991; Ost, 1989). In
particular, the treatm ent was effective in significantly reducing fear on behavioral
m easures (i.e., B A T Distance, SU D S, B aseline SU D S, etc). Clinically sig n ifican t
im provem ents w ere found for 66% o f the participants in relation to the B A T C o n tact
and D istance, 80% for B aseline SU D S, and 82% for not meeting partial o r full
diagnostic criteria for the treatm ent anim al. T hese participants functioned w ithin the
non-phobic range follow ing treatm ent. T h e self-report m easures were the least likely
to show clinically significant im provem ents. This w as consistent w ith the previous
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study (K och et al., 1998) that utilized the behavioral one-session exposure treatm ent
procedure. Perhaps the behavioral and cognitive-behavioral one-session exposure
treatm ent procedures produce the greatest benefit for behavioral and subjective
ratings. A nother possibility was that the self-report measures utilized w ere not
sensitive enough to detect the quick reduction o f sym ptom s that occurs with a onesession treatm ent. Only a few participants reported contacting the feared anim al
betw een sessions. Perhaps many participants did not encounter the feared anim al
betw een treatm ent and posttest/follow -up to test the effects o f treatm ent and
determ ine their progress w ith respect to answ ering the questionnaires.
A conflicting finding betw een the present study and previous research
conducted by O st (1989) pertains to participant dropout before or after treatm ent. For
this study, five qualified participants did not com plete treatm ent and three participants
did not com plete the posttest session after finishing treatm ent. Only one participant
dropped out during the treatm ent procedure proper. O st reports zero to m inim al
dropout over the course o f several studies. T he results from this study are consistent
w ith K och et al, 1998, w here eight participants dropped out prior to the treatm ent
session. It is unclear why the differences exist for dropout between these two research
labs. Perhaps a sufficient treatm ent rationale was not provided during the two studies
that utilized the behavioral treatm ent procedure. This may impact treatm ent follow
through.
A lm ost all participants com pleted the entire treatm ent procedure (i.e., handled
the anim al for at least 60 seconds w hile reporting little o r no anxiety). T hirty-one o f
the 38 participants in this study w ere able to m eet that criterion.
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Lim itations o f the Study
O ne lim itation o f this study was a potential selection bias. All participants
were self-referred w ith sm all animal fears in response to advertisem ents for a sm all
anim al phobia treatm ent study. In addition, a m ajority o f the participants were college
students who were receiving extra credit from undergraduate psychology courses
based on research participation. Perhaps som e o f the dropout during the follow -up
sessions was a result o f students who were no longer receiving extra credit for their
participation. A dditionally, som e students were not available for follow-up sessions
because o f extended breaks (i.e., sum m er vacation) o r not returning to the university
for the follow ing academ ic year.
A nother possible lim itation o f this study was the incorporation of participants
w ith full and partial diagnostic criteria for anim al phobia. H ow ever, no differences
w ere found in baseline m easures, treatm ent effectiveness, or dropout for either
diagnostic group. The A D IS-IV specific phobia section and the inability to touch the
feared animal during baseline were the inclusion criteria for animal phobia. Perhaps
the use o f a threshold o f sym ptom severity based on the A D IS-IV , FSS, or SPQ
w ould have elim inated the one participant who fell w ithin the functional group at
baseline based on the FSS and SPQ. In addition, four participants met criteria for
inclusion based on the AD IS-IV , but were able to touch the animal during the
baseline BAT. Future studies should include additional criteria o f a minimal cut-off
on a m easure found to distinguish phobic from non-phobic individuals.
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H SIRB Project Num ber 99-02-09

T his letter will serve as confirm ation that your research project entitled
“C om p ariso n and Generalization o f C ognitive-B ehavioral and B ehavioral O neS ession E xposure Treatments o f Sm all A nim al Phobias” has been a p p ro v e d
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B oard. T h e conditions and duration o f this approval are specified in the Policies
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noted below . In addition if there are any unanticipated adverse reactions or
u n anticipated events associated with the conduct o f this research, you should
im m ediately suspend the project and contact the C hair of the HSIRB for
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animal handling, administration o f anesthetics, analgesics, and euthanasia to be used in this project.
If this project is funded by an extramural source, I certify that this application accurately reflects all
procedures involving laboratory animal subjects described in the proposal to the funding agency noted
above.
Any proposed revisions to or variations from the animal care and use data will be promptly forwarded to
the LACUC for approval.
Disapproved

Approved

K

Approved with the provisions listed below

Provisions or Explanations:
i_iL : ________ r t c r - c .

__________________________________________________________

/

/.

,/7j
Date

i

IACUCtlhaifpe]:rson
Acceptance o f Provisions

Signature: Princi]

Date

;ator

irperson Final Approval

Approved IACUC Number
R ev. 3 /9 2

IAC-B
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Small Animal Phobia/Fear Treatment Study
Clinical researchers at Western Michigan University are
currently seeking individuals to participate in a treatment
study that will evaluate the treatment of the following
small animal fears:

Snakes
Spiders
Rats/Mice
Crawling Insects

If you currently experience intense fear or avoidance in the
presence of the above animals you may be eligible for
participation in this study. Participation will involve
answering several questionnaires during several sessions
and one treatment session at WMU. You must be at least 18
years old to participate. If you would like to find out more
about this study please contact Ellen or Andrea at 387-4332.
Please leave a message indicating your name, phone number
and the best time to reach you.
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Recruitment Script
Introduce yourself-Today, I am going to talk to you about a research study being
conducted

through

the clinical

psychology

departm ent at W estern

M ichigan

U niversity in hopes o f recruiting participants.

This study is for individuals w ho experience intense fear o r avoidance o f the
follow ing sm all animals: snakes, spiders, rats, mice, or craw ling insects. This study is
a treatm ent study so participants w ill receive free treatment for their fears during the
course o f the study. It entails filling out questionnaires and answ ering several
questions during several sessions, along w ith one treatment session. T he first session
takes approxim ately f /2 hours to com plete and will determ ine if you qualify to
participate in the study. The second session is the treatm ent session, and the longest
session, lasting no more than three hours. This session can be com pleted in a shorter
am ount o f time, but this m uch tim e is allow ed if needed. Several o th er follow -up
sessions are approxim ately Vi h o u r each in length.

If you or som eone you know m ay be interested in participating in this study or w ould
like to learn more about the study, please take a card. The card has a phone num ber
w here you can reach us for questions. W hen you call please leave your nam e, phone
#, and the best time to call and som eone will get back to you. (Pass the cards out)

T hank you for your time.
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Participation in an Investigation
Western Michigan University
Department o f Psychology
Principal Investigator: C. Richard Spates, Ph.D.
Research Associates: Ellen I. Koch, M.A. & Andrea L. Kozak, M.A.
I have been invited to participate in a research project entitled “Comparison
and Generalization o f Behavioral and Cognitive-Behavioral One-Session Exposure
Treatments for Small Animal Phobias.” This research is intended to study the
effectiveness and generalizability o f two different one-session exposure treatments
for small animal phobias. The information collected from this study may be used for
Ellen Koch’s dissertation project.
I will be asked to attend seven private sessions at least one week apart and o f
no more than one hour each in length except for the first and second sessions, which
will be two and three hours maximum respectively. I will be asked to meet with a
research assistant for these sessions at Western Michigan University. The first
session w ill involve completing a screening questionnaire and one diagnostic
interview, Anxiety Disorders Interview Schedule for DSM-IV to determine if I
qualify for the study. If the questionnaire and interview indicate that I will be
excluded from the remainder o f the study, I will be provided with a therapist referral
list including the services offered at the Psychology Clinic, Western Michigan
University. The second part o f the first session will involve completing four more
questionnaires, the Fear Survey Schedule, a specific fear measure, Thought Checklist,
and Cognitive-Somatic Anxiety Questionnaire. I will also complete a Behavioral
Avoidance Test, which w ill consist o f attempting to come as close as possible with
the animal that I fear. I will also be asked to rate the amount o f anxiety I am feeling,
my phobia severity and expected success for treatment. The second session will
involve a treatment procedure that will be only one-session and a maximum o f 3
hours in length. During this treatment procedure the therapist will gradually assist me
in overcoming my fear and avoidance o f the animal. I will be asked to rate my level
o f discomfort in the presence o f the animal throughout treatment. The third session
will involve completing five questionnaires, the Fear Survey Schedule, a specific fear
measure, Thought Checklist, Cognitive-Somatic Anxiety Questionnaire, and the
Distressed Evaluation Scale, the Behavioral Avoidance Test, and rating o f
discomfort, phobia severity and treatment success. The one-month, three-months, sixmonths and one-year follow-up sessions will be the same as the third session without
the Distressed Evaluation Scale. The Behavioral Avoidance Test and the entire
treatment session will be videotaped.
If I choose not to participate in this research study, I may receive a similar
treatment for my small animal fear from the Psychology Clinic. As in all research,
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there may be unforeseen risks to the participant. If an accidental injury occurs,
appropriate emergency measures will be taken; however, no compensation or
additional treatment will be made available to me except as otherwise stated in this
consent form. One potential risk o f my participation in this project is that I may be
emotionally upset in the presence of the feared animal (during the Behavioral
Avoidance Test and treatment). However, trained therapists are prepared to terminate
the treatment session and provide crisis counseling should I become significantly
upset and s/he is prepared to make a referral if I need further counseling about this
topic. I will be responsible for the cost o f therapy if I choose to pursue it Should I
receive a bite from the animal, the research assistants w ill offer immediate first aid
treatment and refer me to emergency medical personnel for further evaluation. I will
be responsible for any medical costs from this evaluation.
One way in which I may benefit from this study is to eliminate my fear o f the
specific animal. Both o f these treatments have been shown to be effective for others
with small animal phobias similar to mine. Others with small animal phobias may
benefit from the knowledge that is gained from this research. Once the study is
completed, I may also receive a general summary o f the results if I wish.
All the information collected from me is confidential. That means that my
name w ill not appear on any papers on which this information is recorded. The forms
will all be coded, and the investigators will keep a separate master list with the names
o f participants and the corresponding code numbers. Once the data are collected and
analyzed, the master list will be destroyed. All other forms w ill be retained for a
minimum o f five years in a locked file in 2505 Wood Hall.
I may refuse to participate or quit at any time during the study without
prejudice, penalty, or risk o f any loss o f service I would otherwise have. If I have any
questions or concerns about this study, I may contact either Ellen Koch or Andrea
Kozak at 387-8303 exL 1 or Dr. Richard Spates at 387-4332. I may also contact the
Chair, Human Subjects Institutional Review Board (387-8293) or the Vice President
for Research (387-8298) if questions or problems arise during the course o f the study.
This consent document has been approved for use for one year by the Human
Subjects Institutional Review Board (HSIRB) as indicated by the stamped date and
signature o f the board chair in the upper right comer o f each page. Subjects should
not sign this document if the comer does not show a stamped date and signature.
My signature below indicates that I have read and/or had explained to me the
purpose and requirements o f the study and that I agree to participate.

Signature

Date

Consent obtained by: _________________________
Initials o f Researcher

____
Date
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Diagram of Participant Flow through the Study
R andom Selection

I

Screening/B aseline Session

I

R andom A ssignm ent

Cognitive-Behavioral T reatm ent
(18 participants)

Behavioral Treatm ent
(20 participants)

I

I

Treatm ent Session

Treatm ent Session

I

Posttest Session

Posttest Session

Program m ed
G eneralization
(10 participants)

1

N on-Program m ed
G eneralization
(10 participants)

I

Follow -up

Follow -up

O ne-M onth
Three-M onths

O ne-M onth
Three-M onths

Program m ed
G eneralization
(9 participants)

N on-Program m ed
G eneralization
(9 participants)

I

Follow -up
O ne-M onth
Three-M onths
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Behavior Avoidance Test (BAT) Distance Scoring Steps
0 = D oes not enter the room
1 = C om pletely crosses the line at #1
2 = C om pletely crosses the line at #2
3 = C om pletely crosses the line at #3
4 = C om pletely crosses the line at #4
5 = C om pletely crosses the line at #5
6 = C om pletely crosses the line at #6
7 = C om pletely crosses the line at #7
8 = C om pletely crosses the line at #8
9 = C om pletely crosses the line at #9
10 = C om pletely crosses the line at #10
11 = C om pletely crosses the line at #11
12 = C om pletely crosses the line at #12
13 = C om pletely crosses the line at #13
14 = Leans forw ard and looks in cage.
15 = T ouches the outside o f the animal cage.
16 = T ouches the top o f the animal cage.
17 = T ouches the bottom o f the animal cage aw ay from the anim al.
18 = T ouches the bottom o f the animal cage near the anim al.
19 = T ouches the anim al for 0 - 4 seconds not continuously.
20 = T ouches the anim al for less than 4 seconds continuously.
21 = T ouches the anim al for 5 - 1 9 seconds not continuously.
22 = T ouches the anim al for 20 - 60 seconds not continuously.
23 = T ouches the anim al for 5 - 1 9 seconds continuously.
24 = T ouches the anim al for 20 - 39 seconds continuously.
25 = T ouches the anim al for 40 - 59 seconds continuously.
26 = T ouches the anim al for 60 seconds or m ore continuously.
27 = Picks up the anim al for 1 - 1 9 seconds.
28 = Picks up the anim al for 20 - 39 seconds.
29 = Picks up the anim al for 40 - 59 seconds.
30 = Picks up the anim al for 60 seconds or more.
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Participant Number:_______________D ate:_________Observer:__________________
Session (circle one):

B aseline

Treatm ent

Posttest

O bservation Form for B ehavioral A voidance T est (BAT)

Duration Measure: T im e in seconds from beginning o f the BAT until the SU D S.
Total Trial O n e :____________

Total Trial T w o :______________

C ontact tim e :_________________________
(3 minute cut-off)

C ontact tim e :________
(3 m inute cut-off)

Distance Measure: N um ber on last fully passed mark or on BA T criteria.
T rial O n e :_______________

Trial T w o :____________________

SUDS: R ating given by the participant follow ing the assistant’s final verbal prom pt.
T rial O n e :_______________

Trial T w o :____________________

B aseline Level (Step

) S U D S :____________

Overt Responses - Check all that apply:
Trial 1

Trial 2

Shaking/T rem bling

H——1

C rying/E yes W atering

^

H olding S e lf

1 —I

I

I

T urning A w ay/N ot Looking

1— I

1

1

O ther (___________________ )

Comments:

I

^

J

^-----1

I

I

The participant’s response to the BAT and level o f severity:
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Assistant’s and Participant’s rating of phobia severity:
P lease rate the severity o f your p hobia sym ptom s according to the fo llow ing scale:
1 = Sym ptom free and no t disabling.
2 = Slightly severe and disabling.
3 = M oderately severe and disabling.
4 = Excessively severe and disabling.
5 = Extrem ely severe and disabling.

Assistant’s rating for severity of p h ob ia: ___________ (rate prior to asking for the
p articip an t’s rating)

Participant’s rating for phobia severity:_________

Participant’s rating of expected success o f treatment:
H aving now been given the explanation fo r the treatm ent (Having now received the
treatm ent), please express your current level o f confidence regarding the treatm ent
outcom e:
1 = Extrem ely skeptical that the treatm ent will have positive effects
2 = Som ewhat skeptical that the treatm ent will have p o sitiv e effects.
3 = W ithholding ju d g m en t; equally confident and skeptical.
4 = Som ew hat confident th a t the treatm ent will have positive effects.
5 = Extrem ely confident the treatm ent will have positive effects.

P articip an t’s rating for expected success o f tre a tm e n t:__________

Posttest Session Only:
W atched V ideo:

Yes

No
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Participant N u m b e r:______________ D a te :____________

A ssista n t:______________

Screening Interview
W hat specific small anim al fear are you seeking treatm ent for (circle one)?
Snake

Spider

R at/M ouse

C raw ling Insect (w hich type o f insect?)

Have you had this fear for over 6 m onths?

Yes

No

If yes, how lo n g ? _____

A nsw ering N o leads to exclusion fr o m the study.
Have you ever had a history o f the following conditions:
Seizure
Yes

No

N eurological Problem

Yes

No

H eart Disease (i.e., Palpitations)

Yes

No

Lung D isease (i.e., Shortness o f B reath or T rouble Breathing)

Yes

No

Recurring C hest Pain

Yes

No

Stroke

Yes

No

Are you currently experiencing (w ithin the last 30 days) the follow ing conditions:
U lcer

Yes

No

M igraines

Yes

No

Answ ering Yes to any o f the above leads to exclusion fr o m the study.
A re you taking any m edications?

Yes

No

If yes, m edication nam e, dosage am ount, and length o f tim e taking each m edication.

Are any o f the above m edications taken for y o u r phobic condition?

Yes

If yes, are they w orking?
Answ ering Yes leads to exclusion unless m edications are discontinued
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No

L13
Are you currently receiving treatm ent specifically fo r your phobic condition?
Yes

No

If yes, please specify w hat the treatm ent consists of.
A nsw ering Yes leads to exclusion fr o m this study.

Do you feel you use drugs or alcohol to help relieve anxiousness caused by your
phobia?

Yes

No

Are you available for six m ore sessions over the next year?

Y es

No

A nsw ering No leads to exclusion.

Do you w ant to get rid o f your anim al fear?

Yes

No

If yes, are you w illing and prepared to tolerate som e anxiety during treatm ent?
Yes

No
A nsw ering N o to either question leads to exclusion fr o m this study.

Are you currently receiving any benefits (i.e., insurance com pensation, threat o f a
legal claim , etc.) due to your phobia?

Yes

No

A nsw ering Yes leads to exclusion fr o m this study.

Do you foresee any negative consequences occurring if your p h o b ia is successfully
treated?

Yes

No
A nsw ering Yes leads to exclusion fr o m this study.
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Treatment Steps for All Animals
1. Progressing from the participant’s B A T baseline stopping point to the cage
2. T ouching the outside o f the container - 10 seconds
3. T ouching the container opening w ith fingertips inside the cage - 10 seconds
4. T ouching the inside o f the container, hand on the bottom o f the cage —10 seconds
11. Picking up the anim al with both hands for increasing periods o f tim e up to 60
seconds
12. P icking up the anim al with both hands for more than 60 seconds (not to exceed 3
m inutes)
S pider Specific Treatm ent Steps (one less step than all other anim als)
5. U sing a card to get the spider in a cup - 3 times
6. C hasing the S pider —for increasing periods o f time up to 30 seconds
7. T ouching the spider with two fingers - 3 seconds
8. T ouching the spider for greater periods o f tim e up to 60 seconds
9. C upping the spider for greater periods o f tim e up to 60 seconds
Snake Specific T reatm ent Steps
5. T ouching the snake with tw o fingers - 3 seconds
6. T ouching the snake for greater periods o f tim e up to 60 seconds
7. T ouching the snake from underneath (cupping) for greater periods o f tim e to 60
seconds
8. T ouching the snake with tw o fingers w hile the therapist holds the anim al above
the cage for increasing periods o f tim e up to 60 seconds
9. T ouching the snake with one full hand w hile the therapist holds the anim al above
the cage for increasing periods o f time up to 60 seconds
10. T ouching the snake with both hands w hile the therapist holds the anim al above
the cage for increasing periods o f tim e up to 60 seconds
C raw ling Insect Specific Treatm ent Steps
Steps 5 through 9 are the sam e as for the snake
11. H olding the insect w ith both hands (therapist picks up the anim al) for increasing
periods o f tim e up to 60 seconds
R at/M ouse Specific Treatm ent Steps
Sam e as the steps for the snake except cupping over the top o f the anim al instead o f
underneath
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Animal Interaction Form
P articipant N um ber:

Date:

>

D escribe setting:

>

D escribe anim al (size, kind, etc.):

>

D escribe how felt:

T otal T im e S pent with A nim al

Im m ediately before the interaction:

D uring the interaction:

Im m ediately after the interaction:

>

Please check all the following responses th at you experienced:

□
□
□
□
□
□

Shaking
C rying
H olding Self
T urning Away
Sw eating

□
□
□
□
□

T rem bling
E yes W atering
A sking O thers for Help
C losing Eyes
Scream ing

O ther
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>

Circle the response that best answ ers the question:
A. Rate com fort in interacting w ith the animal:
1 = V ery com fortable —very w illing to interact with the anim al again
2 = Som ew hat com fortable —w illing to interact with the anim al again
3 = Equally com fortable and uncom fortable - may interact w ith animal again
4 = Som ew hat uncom fortable - unw illing to interact w ith the animal again
5 = V ery uncom fortable —very unw illing to interact w ith the animal again
B. Rate sym ptom severity w hen interacting with the animal:
1 = Sym ptom free and not disabling
2 = Slightly severe and disabling
3 = M oderately severe and disabling
4 = Excessively severe and disabling
5 = Extrem ely severe and disabling

C. How m uch distress did you experience?
1
2
none at all

3

4

5
6
7
som ew hat distressed

8

9
very distressed

D. After interacting with the anim al, how m uch distress did you experience for the
next few hours?
1
2
none at all

>

3

4

5
6
7
som ew hat distressed

8

Any A dditional C om m ents:
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Table A
Means and Standard Deviations of Dependent Measures

M easure and Session

Behavioral
Treatm ent

C ognitiveB ehavioral
T reatm ent

F ear Survey Schedule - Specific A nim al Item
B aseline

5.05

(0.85)

4.69 (0.83)

Posttest

3.95

(0.98)

3.60 (0.80)

1-M onth F ollow -up

3.3 6 (1 .1 0 )

3 .5 0 (1 .1 8 )

3-M onth F ollow -up

3.6 0 (0 .9 9 )

3.21 (1.06)

F ear Survey Schedule - Sm all A nim al F actor
B aseline

3.36

(0.56)

3.01 (0.52)

Posttest

3.00

(0.40)

2.63 (0.37)

1-M onth Follow -up

2.77

(0.40)

2.60 (0.50)

3-M onth Follow -up

2.83

(0.53)

2.56 (0.52)

B aseline

19.70(5.69)

19.33 (5.72)

Posttest

14.45(6.83)

1 3 .9 4 (6 .2 8 )

1-M onth Follow -up

12.08(7.17)

13.71 (6.60)

3-M onth Follow -up

15.25(8.71)

1 1 .2 0 (6 .6 8 )

Specific Phobia Questionnaire - V igilance
B aseline

7.35 (2.72)

5.89 (2.25)

Posttest

5.50 (3.10)

4.29 (2.34)

1-M onth Follow -up

5.33 (3.89)

4 .0 0 (2.45)

3-M onth Follow -up

6.25 (4.95)

3.60 (2.59)

Specific Phobia Questionnaire - Total
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Table A-Continued

M easure and Session

Behavioral
Treatm ent

C ognitiveB ehavioral
T reatm ent

Specific P hobia Q uestionnaire —Preoccupation
B aseline

4.50 (2.70)

4.17 (2.48)

Posttest

3.15 (2.46)

3 .1 2 (2 .5 5 )

1-M onth Follow -up

1.75 (2.22)

2.86 (2.48)

3-M onth Follow -up

2.38 (2.26)

2.20 (2.30)

Specific Phobia Q uestionnaire - A voidance
B aseline

5.70 (2.08)

7.00 (3.16)

Posttest

3.70 (2.41)

5.06 (2.77)

1-M onth Follow -up

3.50 (2.54)

5.29 (3.17)

3-M onth Follow -up

4.75 (2.82)

4.3 0 (2.98)

Specific Phobia Q uestionnaire - C ognitiveB ehavioral Item s
B aseline

2.15 (0.99)

2.22 (1.17)

Posttest

2.1 0(1.07)

1.47 (0.80)

1-M onth Follow -up

1.50(1.24)

1.57 (0.76)

3-M onth Follow -up

1.87(1.25)

1.1 0 (0 .5 7 )

Baseline

12.90 (5.97)

13.61 (6.57)

Treatm ent

12.88 (6.58)

10.06 (5.96)

Posttest

6.20 (4.48)

5.56 (4.38)

1-M onth Follow -up

4.33 (4.77)

4.67 (4.58)

3-M onth Follow -up

6.11 (4.94)

4.5 0 (4.03)

T hought C hecklist N egative
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Table A-Continued

Behavioral
Treatm ent

C ognitiveB ehavioral
T reatm ent

Baseline

1.95 (1.39)

2.06 (1.30)

Treatm ent

3.29 (1.05)

3.06 (0.83)

Posttest

2.45 (1.57)

2.50 (1.29)

1-M onth Follow-up

1.92(1.68)

1.93 (1.71)

3-M onth Follow-up

1.89 (1.27)

2.70 (1.34)

C ognitive-Som atic A nxiety Q uestionnaire C ognitive
Baseline

14.75 (6.97)

14.56 (5.60)

Posttest

10.45 (4.75)

9.28 (2.24)

1-M onth Follow-up

8.92 (3.96)

9.07 (2.89)

3-M onth Follow-up

9.11 (2.57)

9.30 (3.13)

C ognitive-Som atic A nxiety Q uestionnaire Som atic
Baseline

14.95 (4.64)

15.94 (5.27)

Posttest

11.05 (4.35)

9.61 (2.30)

1-M onth Follow-up

10.58 (4.66)

9.47 (2.29)

3-M onth Follow-up

10.67 (4.64)

10.20 (3.82)

Baseline

10.45 (4.83)

9.61 (5.56)

Treatm ent

28.00 (5.02)

29.06 (3.33)

Posttest

26.20 (5.76)

26.00 (6.25)

1-M onth Follow-up

28.58 (3.32)

26.60 (6.17)

3-M onth Follow-up

27.33 (5.39)

26.40 (7.72)

M easure and Session

T hought C hecklist Positive

B ehavioral A voidance T est Distance
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Table A-Continued

Behavioral
Treatment

C ognitiveBehavioral
Treatm ent

0.00 (0.00)

0.00 (0.00)

Treatm ent

153.20 (65.46)

161.67 (52.80)

Posttest

118.15 (87.18)

124.11 (78.66)

1-M onth Follow-up

153.83 (61.36)

123.87 (78.41)

3-M onth Follow-up

146.67 (67.82)

144.00 (75.89)

62.40 (26.54)

57.11 (31.04)

8 .1 0 (1 4 .4 9 )

9.56 (13.71)

29.30 (25.32)

26.11 (23.60)

1-M onth Follow-up

7.92 (14.43)

2 8 .0 0 (3 1 .6 7 )

3-M onth Follow-up

6.22 (8.41)

18.50 (24.16)

62.40 (26.54)

57.11 (31.04)

Treatm ent

1.50 (3.19)

3.72 (8.33)

Posttest

3.61 (8.37)

4.18 (6.87)

1-M onth Follow-up

1.25 (3.11)

7.00 (11.92)

3-M onth Follow-up

3.67 (7.28)

9.70 (16.08)

Baseline

3.35 (1.18)

3.33 (1.14)

Treatm ent

1.65 (1.23)

1.33 (0.77)

Posttest

1.65 (0.93)

2 .0 0 (1 .1 9 )

1-M onth Follow-up

1.17 (0.39)

1.64 (0.93)

3-M onth Follow-up

1.44 (1.01)

1.70(1.06)

Measure and Session

B ehavioral A voidance T est C ontact Time
Baseline

B ehavioral A voidance T est SU D S Rating
Baseline
Treatm ent
Posttest

B aseline Behavioral A voidance T est SUDS
Baseline

T h erapist Rating o f Phobia Severity
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Table A-Continued

M easure and Session

B ehavioral
T reatm ent

CognitiveBehavioral
Treatm ent

Baseline

2.90 (0.97)

3 .00(1.03)

Treatm ent

2.05 (0.94)

1.78 (0.88)

Posttest

1 .8 0 (1 .0 1 )

1.78 (0.81)

1-M onth Follow-up

1.42 (0.51)

1.60 (0.91)

3-M onth Follow-up

1.22 (0.44)

1.60(1.07)

Baseline

3 .3 0 (1 .2 2 )

2.94 (0.80)

Treatm ent

4.05 (1.10)

4.22 (0.88)

Posttest

3.95 (1.10)

4.22 (0.73)

1-M onth Follow-up

3.92 (1.08)

4 .0 0 (1 .0 0 )

3-M onth Follow-up

3.78 (1.20)

4 .3 0 (1 .0 6 )

B ehavioral A voidance T est C ognitive-Som atic
A nxiety Q uestionnaire - C ognitive
Baseline

16.90 (7.88)

16.83 (6.84)

Treatment

10.30 (4.45)

9.89 (4.11)

Posttest

9.95 (4.88)

10.00 (4.33)

1-M onth Follow-up

7.92 (2.02)

8.40 (2.72)

3-M onth Follow-up

7.22 (0.44)

9.20 (3.55)

P articipant R ating o f P hobia Severity

E xpected Success o f T reatm ent
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Table A-Continued

M easure and Session

B ehavioral
Treatm ent

CognitiveBehavioral
Treatm ent

Behavioral A voidance T est Cognitive-Som atic
A nxiety Q uestionnaire —Som atic
Baseline

17.85 (5.59)

17.89 (5.12)

Treatm ent

11.90 (5.23)

10.06 (2.01)

Posttest

12.40 (4.49)

11.61 (3.96)

1-M onth Follow-up

9.25 (2.26)

9.27 (3.22)

3-M onth Follow-up

8 .2 2 (1 .3 0 )

9.40 (3.98)

Behavioral A voidance T est Cognitive-Som atic
A nxiety Q uestionnaire - C ognitive, NonTreatm ent A nim als
1-M onth Follow-up

11.82 (6.91)

9.93 (5.05)

3-M onth Follow-up

12.33 (8.28)

9.70(4.14)

Behavioral A voidance T est Cognitive-Som atic
A nxiety Q uestionnaire —Som atic, NonTreatm ent Animals
1-M onth Follow-up

14.00 (5.44)

12.27 (4.73)

3-M onth Follow-up

12.78 (6.65)

9.80 (2.66)

Therapist Rating o f P hobia Severity - NonT reatm ent Anim als
1-M onth Follow-up

2 .5 5 (1 .0 4 )

2 .1 4(0.95)

3-M onth Follow-up

2.50 (0.93)

2 .1 0(1.29)

Participant Rating o f Phobia Severity - NonTreatm ent Anim als
1-M onth Follow-up

2 .6 4 (1 .3 6 )

2.07 (0.96)

3-M onth Follow-up

2.13 (1.36)

1.90(1.10)
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